false FY 0001584693

 2025-01-31

 2025-10-27

 2025-05-01

 us-gaap: NonrelatedPartyMember

 us-gaap: NonrelatedPartyMember

 us-gaap: RelatedPartyMember

 us-gaap: RelatedPartyMember

 srt: MinimumMember

 us-gaap: PatentsMember

 us-gaap: ComputerSoftwareIntangibleAssetMember

 SSGC:WebsiteRelatedCostMember

 us-gaap: SellingGeneralAndAdministrativeExpensesMember

 us-gaap: SellingGeneralAndAdministrativeExpensesMember

 SSGC:IntangibleAssetsInProcessMember

 SSGC:IntangibleAssetsUnderDevelopmentMember

 SSGC:WebsiteMember

 us-gaap: ComputerSoftwareIntangibleAssetMember

 us-gaap: PatentsMember

 SSGC:WebsiteMember

 us-gaap: PatentsMember

 SSGC:PlatinumNoteOneMember

 2023-06-12

 SSGC:PlatinumNoteOneMember

 2023-06-12
 2023-06-12

 SSGC:PlatinumNoteTwoMember

 2023-12-12

 SSGC:PlatinumNoteTwoMember

 2023-12-12
 2023-12-12

 SSGC:PlatinumNoteThreeMember

 SSGC:PlatinumNoteThreeMember

 SSGC:PlatinumNoteFourMember

 2024-12-31

 SSGC:PlatinumNoteFourMember

 2024-12-31
 2024-12-31

 SSGC:SpouseOfCEOAndChairmanOfBoardOfDirectorsMember

 SSGC:PlatinumNoteFourMember

 2018-03-31

 2018-03-01
 2018-03-31

 2020-08-10
 2020-08-11

 2020-08-11

 2025-04-30

 2025-04-30

 2024-08-25
 2024-08-25

 2024-08-25

 2024-09-01
 2024-09-01

 2024-09-01

 2024-09-20
 2024-09-20

 2024-09-20

 2024-09-26
 2024-09-26

 2024-09-26

 2024-10-08
 2024-10-08

 2024-10-08

 2024-10-10
 2024-10-10

 2024-10-10

 2024-10-18
 2024-10-18

 2024-10-18

 SSGC:ConsultantsMember

 2024-10-19
 2024-10-19

 SSGC:ConsultantsMember

 2024-10-19

 2024-10-21
 2024-10-21

 2024-10-21

 2024-10-22
 2024-10-22

 2024-10-22

 2024-10-24
 2024-10-24

 2024-10-24

 SSGC:ChiefStrategyOfficerMember

 SSGC:ChiefStrategyOfficerMember

 2024-10-31
 2024-10-31

 2024-10-31

 2024-11-01
 2024-11-01

 2024-11-01

 2024-11-05
 2024-11-05

 2024-11-05

 2024-11-06
 2024-11-06

 2024-11-06

 2024-11-11
 2024-11-11

 2024-11-11

 SSGC:LenderMember

 2024-11-13
 2024-11-13

 SSGC:LenderMember

 2024-11-13

 2024-11-19
 2024-11-19

 2024-11-19

 srt: ChiefFinancialOfficerMember

 srt: ChiefFinancialOfficerMember

 2024-12-05
 2024-12-05

 2024-12-05

 2024-12-20
 2024-12-20

 2024-12-20

 2025-01-02
 2025-01-02

 2025-01-02

 2025-01-06
 2025-01-06

 2025-01-06

 2025-01-15
 2025-01-15

 2025-01-15

 2025-01-20
 2025-01-20

 2025-01-20

 2025-01-24
 2025-01-24

 2025-01-24

 2025-01-26
 2025-01-26

 2025-01-26

 2025-01-27
 2025-01-27

 2025-01-27

 2025-01-28
 2025-01-28

 2025-01-28

 2025-01-29
 2025-01-29

 2025-01-29

 2025-01-30
 2025-01-30

 2025-01-30

 2025-01-31
 2025-01-31

 2025-01-31

 2025-02-03
 2025-02-03

 2025-02-03

 2025-02-04
 2025-02-04

 2025-02-04

 2025-02-05
 2025-02-05

 2025-02-05

 2025-02-06
 2025-02-06

 2025-02-06

 2025-02-07
 2025-02-07

 2025-02-07

 2025-02-10
 2025-02-10

 2025-02-10

 2025-02-11
 2025-02-11

 2025-02-11

 2025-02-12
 2025-02-12

 2025-02-12

 SSGC:ConsultantsMember

 2025-02-14
 2025-02-14

 SSGC:ConsultantsMember

 2025-02-14

 2025-02-18
 2025-02-18

 2025-02-18

 2025-02-20
 2025-02-20

 2025-02-20

 2025-02-21
 2025-02-21

 2025-02-21

 SSGC:LenderMember

 SSGC:LenderMember

 2025-02-27
 2025-02-27

 2025-02-27

 2025-03-01
 2025-03-01

 2025-03-01

 2025-03-25
 2025-03-25

 2025-03-25

 2025-03-26
 2025-03-26

 2025-03-26

 2025-04-05
 2025-04-05

 2025-04-05

 2025-04-14
 2025-04-14

 2025-04-14

 SSGC:ChiefRevenueOfficerMember

 SSGC:ChiefRevenueOfficerMember

 2025-04-24
 2025-04-24

 2025-04-24

 2025-05-13
 2025-05-13

 2025-05-13

 2025-05-27
 2025-05-27

 2025-05-27

 2025-05-28
 2025-05-28

 2025-05-28

 2025-06-04
 2025-06-04

 2025-06-04

 2025-06-25
 2025-06-25

 2025-06-25

 us-gaap: RelatedPartyMember
 us-gaap: AccountsPayableAndAccruedLiabilitiesMember

 us-gaap: RelatedPartyMember
 us-gaap: AccountsPayableAndAccruedLiabilitiesMember

 us-gaap: AccountsPayableAndAccruedLiabilitiesMember

 us-gaap: AccountsPayableAndAccruedLiabilitiesMember

 SSGC:PlatinumNoteFourMember

 SSGC:BERILoanMember
 SSGC:ApexFundingSourceLLCMember

 2023-09-18

 SSGC:BERILoanMember
 SSGC:ApexFundingSourceLLCMember

 2024-04-18
 2024-04-18

 SSGC:ScottMBoruffMember

 SSGC:ScottMBoruffMember

 SSGC:ScottMBoruffMember

 SSGC:ScottMBoruffMember
 us-gaap: SubsequentEventMember

 SSGC:DrReyesMember
 SSGC:EmploymentAgreementMember

 SSGC:DrReyesMember
 SSGC:EmploymentAgreementMember

 SSGC:DustinMHillisMember
 SSGC:NonEmployeePresidentAndChiefStrategyOfficerEngagementAgreementMember

 SSGC:DustinMHillisMember
 SSGC:NonEmployeePresidentAndChiefStrategyOfficerEngagementAgreementMember

 SSGC:DustinMHillisMember
 SSGC:NonEmployeePresidentAndChiefStrategyOfficerEngagementAgreementMember
 us-gaap: SubsequentEventMember

 SSGC:MrBradyMember
 SSGC:ChiefFinancialOfficerEngagementAgreementMember

 2024-10-01
 2024-10-01

 SSGC:MrBradyMember
 SSGC:ChiefFinancialOfficerEngagementAgreementMember

 SSGC:MrBradyMember
 SSGC:ChiefFinancialOfficerEngagementAgreementMember
 us-gaap: SubsequentEventMember

 SSGC:MrAnandIjjuMember
 SSGC:ChiefTechnologyOfficerMember

 2025-04-10
 2025-04-10

 SSGC:MrTheoDaviesMember
 SSGC:ChiefRevenueOfficerMember

 UNITED
STATES

 SECURITIES
AND EXCHANGE COMMISSION

 Washington,
D.C. 20549

 FORM

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the fiscal year ended July 31, 2025

 OR

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For
the transition period from ________ to ________

 Commission
file number: 001-36564

Global Corporation

 (Exact
Name of Registrant as Specified in its Charter)

 Nevada

 85-1173741

 (State
 or Other Jurisdiction

 of
 Incorporation or Organization)

 (I.R.S.
 Employer

 Identification
 No.)

S. Weisgarber Road

 Knoxville,
 TN 37919

 (Address
of Principal Executive Offices)

 Registrant's
telephone number, including area code: (865) 237-4448

 Securities
registered pursuant to Section 12(b) of the Act: None

 Securities
registered pursuant to section 12(g) of the Act:

 Common
Stock, $0.001 par value

by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. Yes No

by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes
 No

by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes No

by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
 Yes No

by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller
reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large
 accelerated filer

 Accelerated
 filer

 Non-accelerated
 filer

 Smaller
 reporting company

 Emerging
 growth company

 If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.

 If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements.

by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).

by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 The
aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant on January 31, 2025 (the last
business day of the registrant's most recently completed second quarter) based upon the closing price of Common Stock on such date
as reported on the OTC Pink market, was approximately $ 33 million. As of October 27, 2025, there were 187,511,196 shares of common stock
of the registrant outstanding.

 Documents
Incorporated by Reference: None.

 TABLE
OF CONTENTS

 PART
 I

 ITEM
 1. BUSINESS.

 ITEM
 1A. RISK FACTORS.

 ITEM
 1B. UNRESOLVED STAFF COMMENTS.

 ITEM
 2. PROPERTIES.

 ITEM
 3. LEGAL PROCEEDINGS.

 ITEM
 4. MINE SAFETY DISCLOSURES.

 PART
 II

 ITEM
 5. MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 ITEM
 6. SELECTED FINANCIAL DATA.

 ITEM
 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 ITEM
 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 ITEM
 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 ITEM
 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 ITEM
 9A. CONTROLS AND PROCEDURES.

 ITEM
 9B. OTHER INFORMATION

 PART
 III

 ITEM
 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 ITEM
 11. EXECUTIVE COMPENSATION.

 ITEM
 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 ITEM
 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 ITEM
 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 PART
 IV

 ITEM
 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 SIGNATURES

 CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS

 This
Annual Report on Form 10-K (this "Report") contains "forward-looking statements" within the meaning of the Section
27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"). Forward-looking statements discuss matters that are not historical facts. Because they discuss
future events or conditions, forward-looking statements may include words such as "anticipate," "believe," "estimate,"
"intend," "could," "should," "would," "may," "seek," "plan,"
"might," "will," "expect," "predict," "project," "forecast,"
"potential," "continue", negatives thereof or similar expressions. These forward-looking statements are found
at various places throughout this Annual Report and include information concerning: possible or assumed future results of our operations;
business strategies; future cash flows; financing plans; plans and objectives of management; any other statements regarding future operations,
future cash needs, business plans and future financial results; and any other statements that are not historical facts.

 From
time to time, forward-looking statements are also included in our other periodic reports on Forms 10-Q and 8-K, in our press releases,
in our presentations, on our website and in other materials released to the public. Any or all the forward-looking statements included
in this Annual Report and in any other reports or public statements made by us are not guarantees of future performance and may turn
out to be inaccurate. These forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future
events and are subject to risks, uncertainties and other factors. Many of those factors are outside of our control and could cause actual
results to differ materially from the results expressed or implied by those forward-looking statements. Considering these risks, uncertainties
and assumptions, the events described in the forward-looking statements might not occur or might occur to a different extent or at a
different time than we have described. You are cautioned not to place undue reliance on these forward-looking statements, which speak
only as of the date of this Annual Report. All subsequent written and oral forward-looking statements concerning other matters addressed
in this Annual Report and attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary
statements contained or referred to in this Annual Report.

 Except
to the extent required by law, we undertake no obligation to update or revise any forward-looking statements, whether as a result of
new information, future events, a change in events, conditions, circumstances or assumptions underlying such statements, or otherwise.

 For
discussion of factors that we believe could cause our actual results to differ materially from expected and historical results see "Item
1A - Risk Factors" below.

 PART
I

 ITEM
1. BUSINESS.

Global Corporation (collectively the "Company," "we," "our" or "us") is a multimodal
AI technology solutions company with a dedicated team focused on driving safety innovation across multiple industries. We are currently
marketing products and solutions that utilize advanced AI tools to monitor and enhance resident safety, reduce the risk of injuries,
and improve overall care efficiency.

 In
April 2025, we completed a strategic rebranding initiative, adopted our current corporate name SafeSpace Global Corporation, and transitioned
to the trading symbol "SSGC" for our common stock. These changes reflect our expanded mission to deliver life-saving multimodal AI technology solutions across a wide range of environments beyond healthcare, including schools, transit systems, correctional
facilities, and commercial infrastructure. With operations spanning the United States, Europe, Singapore, and India, our branding supports
SafeSpace's evolution into a technology-driven global enterprise dedicated to protecting lives wherever people live, learn, travel,
or work. We believe that this transformation strengthens our market positioning and aligns our corporate identity with our broadened
strategic vision.

 Business
Overview

 We
market the following products and solutions, including our initial product, SafeSpace Fall Monitoring, which utilizes advanced AI
monitoring tools to enhance resident safety in senior living, reduce the risk of injuries, and improve overall care efficiency. Additionally,
we have expanded our services and offerings beyond senior living facilities, into schools and transportation where we've recently
launched these innovative solutions:

 SafeFace
 Access Control – An advanced solution that leverages facial recognition to automatically
 and instantly unlock doors for registered staff and visitors, integrating seamlessly with
 your existing maglock system for a completely keyless and no badge entry.

 SafeFace
 Time Compliance – A platform that monitors staff movements, rounds, and care tasks
 in real time, delivering actionable insights to leadership. These insights enable more informed
 decision-making and help streamline daily operations.

 SafeGuard
 Wander Protection – Strategically-placed facial recognition cameras that trigger
 alerts when an at-risk resident is seen outside your secured unit, reducing immediate jeopardy
 situations and litigation.

 SafeTrace
 Rapid Investigations – An innovative investigation solution—simply select
 a face to instantly retrieve video clips of that individual across your facilities, anytime.
 Local data storage ensures security and cost efficiency, saving countless hours in investigations.

 SafeSchool
 – Designed to address growing concerns around school safety by proactively detecting
 weapons and identifying persons of concern through real-time AI-based monitoring. The SafeSchool
 multimodal AI solution is designed to help protect students during school hours while
 offering peace of mind to guardians. The SafeSchool product offers proactive protection
 that cameras on their own cannot provide. Our software proactively alerts when weapons are
 detected or persons of concern (i.e. predators or non-custodial parents) are sighted, offering
 immediate situational awareness to deter a tragedy. We are actively working with external
 advisors, school administrators, and legal counsel to ensure that SafeSchool is deployed
 in a FERPA-compliant manner. We view FERPA compliance as a priority and are committed to
 aligning the SafeSchool offering with applicable privacy laws.

 Research
and Development

 To
support the delivery and commercialization of these solutions, management appointed a new Chief Technology Officer (CTO) in April and
has engaged a specialized team of consultants. These strategic investments are intended to accelerate product development, improve time-to-market,
and create long-term stockholder value by establishing sustainable revenue streams.

Global Corporation is executing a focused growth strategy led by a world-class team of executives with deep experience in scaling innovative
companies. Our leadership team combines proven operational expertise with a mission-driven commitment to safety and impact. Our primary
objective is to expand the adoption of our life-saving multimodal AI technology across both existing and emerging verticals.
These include senior living, education, transportation, and corrections—with future expansion planned into commercial infrastructure
and high-risk institutional settings. To support this growth, we have strengthened our development team with additional senior IT architects,
AI specialists, and systems engineers who are accelerating product innovation and market deployment on a global scale. A key pillar of
this strategy is our dedicated sales force, which brings both deep domain knowledge and a shared commitment to leveraging AI
to save lives. This integrated team is actively driving customer engagement, market penetration, and adoption of our multimodal safety
solutions across diverse environments.

 Intellectual
Property

 We
have been granted two U.S. patents that further reinforce our proprietary technology portfolio:

 US
 Patent No. 11,587,423, titled Fall Validation with Privacy-Aware Monitoring, is an advanced system for detecting, confirming,
 and mitigating falls while prioritizing user privacy. Leveraging AI, audio, and selective image capture, it delivers reliable fall
 detection without invasive surveillance.

 US
 Patent No. 11,886,950, titled System and Method for Assessing and Verifying the Validity of a Transaction is a transaction
 validation system that uses AI and multi-sensor data to ensure compliance across healthcare, logistics, and industrial operations.
 It redefines accountability and safety by proactively identifying anomalies and verifying processes.

 We
believe these patents enhance our competitive position in the AI-based monitoring sector and reflect our commitment to protecting both
privacy and lives.

 Our
History

 Our
Company was first incorporated under the laws of the State of Nevada in 2013, with the name "Tomichi Creek Outfitters," aiming
to provide professionally-guided big game hunts in Sargents, Colorado, which is approximately four hours southwest from Denver and to
offer guided scenic tours on the western slopes of the Rocky Mountains. The Company's common stock became eligible for quotation
on the over-the-counter markets under the symbol "TCKF" in July 2014.

 In
2015, our Company acquired all of the outstanding capital stock of Grasshopper Staffing, Inc., a Colorado corporation, which had a primary
focus on providing employee recruiting, training, and compliance in target industries. The hunting and tour businesses were discontinued
in connection with the closing of this acquisition. Later in 2015, the Company adopted the name "Grasshopper Staffing, Inc."

 In
2018, our Company acquired all of the outstanding capital stock of IndeLiving Holdings Inc., a Florida corporation. The acquired business
consisted primarily of an early-stage business using proprietary technology to monitor seniors in real time. Concurrent with the closing
of the acquisition, a change in control of the Company occurred wherein Scott M. Boruff was appointed CEO and sole director. The staffing
business continued to operate under the oversight of its existing personnel. As a result of the acquisition and new business focus,
the Company adopted the name "Healthcare Integrated Technologies Inc." and commenced quotation on the over-the-counter market
under a new symbol, "HITC," in June 2018. The staffing business was discontinued in early 2019.

 In
April 2025, we completed a strategic rebranding initiative, adopted our current corporate name, SafeSpace Global Corporation, and commenced
quotation on the over-the-counter market under our current symbol, "SSGC," effective April 24, 2025.

 Employees
and Human Capital

 As
of October 23, 2025, we had 32 employees, 17 of which were full-time employees. None of our employees are represented by a labor union
or covered by a collective bargaining agreement. We have not experienced any work stoppages, and we consider our relationship with our
employees to be good.

 Our
objectives surrounding human resources include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our
existing and new employees, advisors and consultants. The principal purpose of our equity incentives are to attract, retain and reward
personnel through the granting of stock-based compensation awards, in order to increase stockholder value and promote the success of
the Company by motivating such individuals to perform to the best of their abilities.

 We
have historically used the services of independent consultants and contractors to perform various professional services. We believe that
this use of third-party service providers enhances our ability to minimize general and administrative expenses. We intend to periodically
evaluate our staffing and talent requirements and expect to add employees if that becomes a more appropriate resource alternative.

 Available
Information

 We
electronically file certain documents with the Securities and Exchange Commission (the SEC). We file annual reports on Form 10-K; quarterly
reports on Form 10-Q; and current reports on Form 8-K (as appropriate); along with any related amendments and supplements thereto. From
time to time, we may also file registration statements and related documents in connection with equity or debt offerings. You may read
and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Washington, DC 20549. You may
obtain information regarding the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an internet
website at www.sec.gov that contains reports and other information regarding registrants that file electronically with the SEC.

 ITEM
1A. RISK FACTORS.

 Risks
Related to Our Business

 The
Company's industry is highly-competitive, and we have less capital and fewer resources than many of our competitors, which may
give competitors an advantage in developing and marketing products similar to ours or make our products obsolete.

 We
participate in a highly competitive industry where we may compete with numerous other companies that offer alternative methods or approaches,
and that may have far greater resources, more experience, and personnel more qualified than we do. Such resources may give our competitors
an advantage in developing and marketing products similar to ours or products that make our products obsolete. There can be no assurance
that we will be able to successfully compete against these other entities.

 The
Company may be unable to respond to the rapid technological change in the industry and such change may increase costs and competition
that may adversely affect our business.

 Rapidly
changing technologies, frequent new product and service introductions and evolving industry standards characterize the Company's
market. The continued growth of the internet and intense competition in the Company's industry exacerbate these market characteristics.
The Company's future success will depend on its ability to adapt to rapidly changing technologies by continually improving the
performance features and reliability of its products and services. The Company may experience difficulties that could delay or prevent
the successful development, introduction or marketing of its products and services. In addition, any new enhancements must meet the requirements
of its current and prospective users and must achieve significant market acceptance. The Company could also incur substantial costs if
it needs to modify its products and services or infrastructures to adapt to these changes.

 The
Company also expects that new competitors may introduce products, systems or services that are directly or indirectly competitive with
the Company. These competitors may succeed in developing products, systems and services that have greater functionality or are less costly
than the Company's products, systems and services, and may be more successful in marketing such products, systems and services.
Technological changes have lowered the cost of operating communications and computer systems and purchasing software. These changes reduce
the Company's cost of providing services but also facilitate increased competition by reducing competitors' costs in providing
similar services. This competition could increase price competition and reduce the Company's anticipated profit margins.

 The
Company's services are new, and its industry is evolving.

 You
should consider the Company's viability by considering the risks, uncertainties and difficulties frequently encountered by companies
in their early stage of development. To be successful in this industry, the Company must, among other things:

 develop
 and introduce functional and attractive services;

 attract
 and maintain a large base of customers;

 increase
 awareness of the Company brand and develop consumer loyalty;

 respond
 to competitive and technological developments;

 build
 an operations structure to support the Company business; and

 attract,
 retain and motivate qualified personnel.

 The
Company cannot guarantee that it will succeed in achieving these goals, and its failure to do so would have a material adverse effect
on its business, prospects, financial condition and operating results.

 The
Company's products and services are new and are in the initial, preliminary or pilot stages of development. The Company is not
certain that these products and services will function as anticipated or be desirable to its intended market. Also, some of the Company's
products and services may have limited functionalities, which may limit their appeal to consumers and put the Company at a competitive
disadvantage. If the Company's current or future products and services fail to function properly or if the Company does not achieve
or sustain market acceptance, it could lose customers or could be subject to claims which could have a material adverse effect on the
Company's business, financial condition and operating results.

 Risks
Related to Our Company

 Our
ability to achieve and maintain profitability is uncertain.

 Our
business strategy may result in increased volatility of future revenues and earnings. As we will only develop a limited number of products
and services at a time, our overall success will depend on a limited number of products and services, which may cause variability and
unsteady profits and losses depending on the products and services offered.

 Because
of the anticipated nature of the products and services that we will attempt to develop, it is difficult to accurately forecast revenues
and operating results, and these items could fluctuate in the future due to several factors. These factors may include, among other things,
the following:

 Our
 ability to raise sufficient capital to take advantage of opportunities and generate sufficient
 revenues to cover expenses.

 Our
 ability to source strong opportunities with sufficient risk adjusted returns.

 Our
 ability to manage our capital and liquidity requirements based on changing market conditions.

 The
 acceptance of the terms and conditions of our licenses and/or the acceptance of our royalties
 and fees.

 The
 amount and timing of operating costs and other costs and expenses.

 The
 nature and extent of competition from other companies that may reduce market share and create
 pressure on pricing and investment return expectations.

 Adverse
 changes in the national and regional economies in which we will participate, including, but
 not limited to, changes in our performance, capital availability, and market demand.

 Adverse
 changes in the projects in which we plan to invest which result from factors beyond our control,
 including, but not limited to, a change in circumstances, capacity and economic impacts.

 Changes
 in laws, regulations, accounting, taxation, and other requirements affecting our operations
 and business.

 Our
operating results may fluctuate from year to year due to the factors listed above and others not listed. At times, these fluctuations
may be significant.

 Management
of growth will be necessary for us to be competitive.

 Successful
expansion of our business will depend on our ability to effectively attract and manage staff, strategic business relationships, and stockholders.
Specifically, we will need to hire skilled management and technical personnel as well as manage partnerships to navigate shifts in the
general economic environment. Expansion has the potential to place significant strains on financial, management, and operational resources,
yet failure to expand will inhibit our profitability goals.

 We
are entering a highly competitive market.

 The
markets for the healthcare and senior monitoring industries are competitive and evolving. We face intense competition from larger companies
that may be in the process of offering comparable products and services to ours. Many of our current and potential competitors have longer
operating histories, significantly greater financial, marketing and other resources and larger client bases than we have or expect to
have in the near future.

 Given
the rapid changes affecting the global, national, and regional economies generally, and the healthcare industry specifically, we may
not be able to create and maintain a competitive advantage in the marketplace. Our success will depend on our ability to keep pace with
any market, legal and regulatory changes as well as competitive pressures. Any failure by us to anticipate or respond adequately to such
changes could have a material adverse effect on our financial condition, operating results, liquidity and cash flow.

 If
we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately
or prevent fraud, and any inability to report and file our financial results accurately and timely could harm our reputation and adversely
impact the future trading price of our common stock.

 Effective
internal control is necessary for us to provide reliable financial reporting and prevent fraud. If we cannot provide reliable financial
reports or prevent fraud, we may not be able to manage our business as effectively as we would if an effective control environment existed,
and our business and reputation with investors may be harmed. As a result, our small size and any current internal control deficiencies
may adversely affect our financial condition, results of operation and access to capital.

 The
Company's failure to continue to attract, train, or retain highly qualified personnel could harm the Company's business.

 The
Company's success also depends on the Company's ability to attract, train, and retain qualified personnel, specifically those
with management and product development skills. In particular, the Company must hire additional skilled personnel to further the Company's
research and development efforts. Competition for such personnel is intense. If the Company fails in attracting new personnel, or retaining
and motivating the Company's current personnel, the Company's business could be harmed.

 Risks
Related to Our Common Stock

 Our
common stock is eligible for quotation on the over-the-counter-market but not listed on any national securities exchange.

 Our
shares of common stock are eligible for quotation on the OTCID Basic market under the symbol "SSGC." Despite eligibility
for quotation on the over-the-counter markets, no assurance can be given that any market for our common stock will develop or, if one
develops, that it will be maintained for any period of time. Quotation on the over-the-counter markets is generally understood to be
a less active, and therefore less liquid, trading market than other types of markets such as a national securities exchange. In comparison
to a listing on a national securities exchange, quotation on the over-the-counter markets is expected to have an adverse effect on the
liquidity of shares of our common stock, both in terms of the number of shares that can be bought and sold at a given price, but also
through delays in the timing of transactions and reduction in analyst and media coverage. This may result in lower prices for our common
stock than might otherwise be obtained and could also result in a larger spread between the bid and ask prices for our common stock.

 We
will likely issue additional shares of our common stock and investment in our Company could be subject to substantial dilution

 Investors'
interests in our company will be diluted and investors may suffer dilution in their net book value per share when we issue additional
shares. We are authorized to issue up to 200,000,000 shares of common stock, $0.001 par value per share. As of October 27, 2025, there
were 187,511,196 shares of our common stock issued and outstanding. We anticipate that all or at least some of our future funding, if
any, will be in the form of equity financing from the sale of our common stock. If we do sell more common stock, investors' investment
in our company will likely be diluted. Dilution is the difference between what you pay for your stock and the net tangible book value
per share immediately after the additional shares are sold by us. If dilution occurs, any investment in the Company's common stock
could seriously decline in value.

 Trading
in our common stock on the OTCID Basic market has been subject to wide fluctuations.

 Our
common stock is currently eligible for quotation on the OTCID Basic market administered by OTC Markets Group Inc. The trading price of
our common stock has been subject to wide fluctuations. Trading prices of our common stock may fluctuate in response to several factors,
many of which will be beyond our control. The stock market has generally experienced extreme price and volume fluctuations that have
often been unrelated or disproportionate to the operating performance of companies with no current business operation. There can be no
assurance that trading prices and price earnings ratios previously experienced by our common stock will be matched or maintained. These
broad market and industry factors may adversely affect the market price of our common stock, regardless of our operating performance.
In the past, following periods of volatility in the market price of a company's securities, securities class-action litigation
has often been instituted. Such litigation, if instituted, could result in substantial costs for us and a diversion of management's
attention and resources.

 Our
Articles of Incorporation and By-Laws provide for indemnification of officers and directors at our expense and limit their liability,
which may result in a major cost to us and hurt the interests of our stockholders due to corporate resources being expended for the benefit
of officers and/or directors.

 Our
Articles of Incorporation and By-Laws include provisions that are designed to fully eliminate the personal liability of our directors
for monetary damages to the fullest extent possible under the laws of the State of Nevada or other applicable law. These provisions eliminate
the liability of our directors and our stockholders for monetary damages arising out of any violation of a director of his fiduciary
duty of due care. Under Nevada law, however, such provisions do not eliminate the personal liability of a director for (i) breach of
the director's duty of loyalty, (ii) acts or omissions not in good faith or involving intentional misconduct or knowing violation
of law, (iii) payment of dividends or repurchases of stock other than from lawfully available funds, or (iv) any transaction from which
the director derived an improper benefit. These provisions do not affect a director's liabilities under the federal securities
laws or the recovery of damages by third parties. Providing indemnification for officers and directors may divert the Company's
time and resources away from development of its primary products and services, which could harm the interests of stockholders.

 We
do not intend to pay dividends on any investment in the shares of common stock of our Company and any gain on an investment in our Company
will need to come through an increase in our stock's price, which may never happen

 We
have never paid any cash dividends on our common stock, and currently do not intend to pay any dividends for the near future. To the
extent that we require additional funding currently not provided for in our financing plan, our funding sources may prohibit the payment
of a dividend. Because we do not intend to declare dividends, any gain on an investment in our company will need to come through an increase
in the price of our common shares. This may never occur, and investors may lose all their investment in our company.

 Our
common stock is a "penny stock," which may make it difficult to sell shares of our common stock.

 Our
common stock is currently categorized as a "penny stock" as defined in Rule 3a51-1 of the Exchange Act and is subject to
the requirements of Rule 15g-9 of the Exchange Act. Under this rule, broker-dealers who sell penny stocks must, among other things, provide
purchasers of these stocks with a standardized risk-disclosure document prepared by the SEC. Under applicable regulations, unless it
becomes listed on a national securities exchange, our common stock will generally remain a "penny stock" until such time
as its per-share price is $5.00 or more (as determined in accordance with SEC regulations), or until we meet certain net asset or revenue
thresholds. These thresholds include the possession of net tangible assets (i.e., total assets less intangible assets and liabilities)
in excess of $2 million or average revenues equal to at least $6 million for each of the last three years.

 The
penny-stock rules significantly limit the liquidity of securities in the secondary market, and many brokers choose not to participate
in penny-stock transactions. As a result, there is generally less trading in penny stocks. If you become a holder of our common stock,
you may not always be able to resell shares of our common stock in a public broker's transaction, if at all, at the times and prices
that you feel are fair or appropriate.

 The
protection provided by the federal securities laws relating to forward-looking statements may not apply to us. The lack of this protection
could harm us in the event of an adverse outcome in a legal proceeding relating to forward-looking statements made by us.

 Although
federal securities laws provide a safe harbor for forward-looking statements made by a public company that files reports under the federal
securities laws, this safe harbor is not available to certain issuers, including "penny stock" issuers. If we are determined
to have issued a "penny stock," we will not have the benefit of this statutory safe harbor protection in the event of certain
legal actions based upon forward-looking statements. The lack of this protection in a contested proceeding could harm our financial condition
and, ultimately, the value of our common stock.

 FINRA
sales practice requirements may also limit a stockholder's ability to buy and sell our stock.

 In
addition to the "penny stock" rules described above, the Financial Industry Regulatory Authority ("FINRA") has
adopted rules requiring that when recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing
that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their non-institutional
customers, broker-dealers must make reasonable efforts to obtain information about the customer's financial status, tax status,
investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that
speculative low-priced securities will not be suitable for at least some customers. FINRA requirements make it more difficult for broker
dealers to recommend that their customers buy our common shares, which may limit your ability to buy and sell our stock and have an adverse
effect on the market for our shares.

 General
Risk Factors

 The
success of any investment activity is influenced by general economic and financial conditions, all of which are beyond the control of
the Company. These conditions, such as the recent global economic concerns and volatility in the financial markets, may materially adversely
affect our operating results, financial condition and ability to implement our business strategy and/or meet our return objectives.

 The
foregoing risk factors are not a complete list or explanation of the risks involved with an investment in our securities. Additional
risks will likely be experienced that are not presently foreseen by the Company. Prospective investors must not construe this information
provided herein as constituting investment, legal, tax or other professional advice. Before making any decision to invest in our securities,
you should read this entire Annual Report and consult with your own investment, legal, tax and other professional advisors. An investment
in our securities is suitable only for investors who can assume the financial risks of an investment in the Company for an indefinite
period and who can afford to lose their entire investment. The Company makes no representations or warranties of any kind with respect
to the likelihood of the success or the business of the Company, the value of our securities, any financial returns that may be generated
or any tax benefits or consequences that may result from an investment in the Company.

 ITEM
1B. UNRESOLVED STAFF COMMENTS.

 Not
applicable.

 ITEM
1C. CYBERSECURITY.

 Cybersecurity
is an integral component of our business operations and software development practices. We are focused on developing secure cloud-based
software solutions, and we recognize the importance of maintaining the confidentiality, integrity, and availability of our information
systems and data.

 Risk
Management and Strategy

 Our
cybersecurity risk exposure primarily involves the protection of source code, confidential development data, and corporate information
stored in cloud-based collaboration and hosting environments. We have implemented cybersecurity risk management practices that are appropriate
for our current size, resources, and operational complexity. These practices include, among others:

 Utilizing
 reputable third-party hosting and version control providers that maintain recognized security
 certifications (e.g., ISO 27001, SOC 2);

 Implementing
 multi-factor authentication for company accounts and administrative access;

 Conducting
 periodic reviews of user credentials and access privileges; and

 Maintaining
 regular, secure backups of source code repositories.

 To
date, we have not identified any cybersecurity incidents that have materially affected, or are reasonably likely to materially affect,
our business strategy, financial condition, or results of operations. As our business grows, we intend to expand our cybersecurity risk
management protocols through the adoption of formal written policies, periodic third-party assessments, and a documented incident response
plan.

 Governance

 The
Board of Directors has ultimate oversight responsibility for cybersecurity risk as part of its overall risk management and corporate
governance framework. Management is responsible for the implementation and monitoring of cybersecurity controls and for reporting material
developments to the Board.

 At
present, we do not employ dedicated cybersecurity personnel due to our limited operational scale and financial resources. We currently conduct due diligence or ongoing reviews of
qualified third-party service providers and advisors to support information security and assist management in identifying and addressing
potential risks. The Board, at least annually, receives periodic updates from management regarding the effectiveness of these measures and any material developments
in our cybersecurity posture.

 ITEM
2. PROPERTIES.

 None.

 ITEM
3. LEGAL PROCEEDINGS.

 As
previously reported, on September 18, 2023, Apex Funding Source, LLC ("Apex") filed a lawsuit in the Supreme Court of the
State of New York, County of New York, alleging breach by Blue Earth Resources, Inc. ("BERI") of a loan agreement and alleged
failure to pay $4,705,900 in principal and interest to Apex when due. The suit names Scott M. Boruff, our CEO and Chairman of the Company's
Board of Directors, "Grasshopper Staffing, Inc.," and "Indeliving Holdings, Inc.," as defendants in the suit.
Apex alleges that Grasshopper Staffing, Inc. and IndeLiving Holdings, Inc. are each guarantors of the loan to BERI, which is an entity
that has common management personnel with our Company. Our Company ceased using the Grasshopper Staffing, Inc. name years before the
facts underlying the dispute arose, and IndeLiving Holdings, Inc. was a wholly-owned subsidiary of our Company that has been administratively
dissolved.

 On
April 18, 2024, Apex filed a motion seeking partial summary judgment against BERI and Mr. Boruff in the amount of $4,705,900, plus their
actual and reasonable attorneys' fees. Neither Grasshopper Staffing,
Inc. nor IndeLiving Holdings, Inc. was included in the order granting partial summary judgment.

 In
the event Apex attempts to enforce the alleged guarantees against our Company, which is not itself a named party to the proceedings,
we believe we have valid defenses. In the judgment of the Company's management, even if the remaining actions were adversely determined,
they would not be reasonably likely to have a direct or indirect material adverse effect on the Company because no remaining subsidiaries exist. Based on
the disposition of the claims against BERI and Mr. Boruff summarized above, we do not expect to provide any further updates on this matter.

 Other
than the foregoing, there are no material pending legal proceedings, other than ordinary routine litigation incidental to our business,
to which we or any of our subsidiaries are a part or of which any of our property is the subject.

 ITEM
4. MINE SAFETY DISCLOSURES.

 Not
applicable.

 PART
II

 ITEM
5. MARKET FOR OUR COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 (a)
Market Information

 Our
common stock is eligible for quotation on the OTCID Basic market administered by OTC Markets Group Inc. under the symbol "SSGC."
The OTCID Basic market is the successor the OTCPink Current Information market and a quotation service that displays real-time quotes,
last-sale prices, and volume information in over-the-counter equity securities.

 The
following table shows, for the periods indicated, the high and low bid prices per share of the Company's common Stock as reported
by OTC Markets Group Inc. The quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily
represent actual transactions.

 High

 Low

 Fiscal Year 2024

 First quarter ended October 31, 2023

 $
 0.14

 $
 0.05

 Second quarter ended January 31, 2024

 $
 0.11

 $
 0.05

 Third quarter ended April 30, 2024

 $
 0.11

 $
 0.04

 Fourth quarter ended July 31, 2024

 $
 0.13

 $
 0.07

 Fiscal Year 2025

 First quarter ended October 31, 2024

 $
 0.16

 $
 0.06

 Second quarter ended January 31, 2025

 $
 0.42

 $
 0.10

 Third quarter ended April 30, 2025

 $
 0.40

 $
 0.23

 Fourth quarter ended July 31, 2025

 $
 1.43

 $
 0.27

 (b)
Holders

 As
of October 27, 2025, there were 127 stockholders of record. Because shares of the Company's common stock are held by
depositaries, brokers and other nominees, the number of beneficial holders of the Company's shares is larger than the number
of stockholders of record.

 (c)
Dividends

 We
have never declared or paid dividends on our common stock. We do not intend to declare dividends in the near future because we anticipate
that we will reinvest any future earnings into the development and growth of our business. Any decision as to the future payment of dividends
will depend on our results of operations and financial position and such other factors as our Board of Directors in its discretion deems
relevant.

 (d)
Securities Authorized for Issuance under Equity Compensation Plan

 As
of July 31, 2025, the Company did not have in effect any compensation plans under which the Company's equity securities are authorized
for issuance.

 Transfer
Agent

 Our
transfer agent is VStock Transfer, LLC located at 18 Lafayette Place, Woodmere, NY 11598.

 Recent
Sales of Unregistered Securities

 On
June 25, 2025, we issued 462,121 shares of common stock to a previous lender pursuant to a make-whole provision included as part of a
loan modification fee. The shares were issued at an estimated value of $0.0665 per share. The issuance of the shares was exempt from
registration under the Securities Act of 1933 in reliance on an exemption provided by Section 4(a)2 of that act.

 Rule
10B-18 Transactions

 None.

 ITEM
6. SELECTED FINANCIAL DATA.

 Not
applicable

 ITEM
7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 THE
FOLLOWING DISCUSSION OF OUR PLAN OF OPERATION AND RESULTS OF OPERATIONS SHOULD BE READ IN CONJUNCTION WITH THE FINANCIAL STATEMENTS AND
RELATED NOTES TO THE FINANCIAL STATEMENTS INCLUDED ELSEWHERE IN THIS REPORT. THIS DISCUSSION CONTAINS FORWARD-LOOKING STATEMENTS THAT
RELATE TO FUTURE EVENTS OR OUR FUTURE FINANCIAL PERFORMANCE. THESE STATEMENTS INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER
FACTORS THAT MAY CAUSE OUR ACTUAL RESULTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS TO BE MATERIALLY DIFFERENT FROM ANY FUTURE
RESULTS, LEVELS OF ACTIVITY, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING
STATEMENTS ARE SUBJECT TO NUMEROUS RISKS AND UNCERTAINTIES, INCLUDING OUR ABILITY TO COMMERCIALIZE NEW PRODUCTS, HIRE AND RETAIN KEY
PERSONNEL, AND SECURE SUFFICIENT FUNDING TO EXECUTE OUR GROWTH PLAN. IF OUR ASSUMPTIONS REGARDING PLANNED EXPENDITURES OR REVENUE GENERATION
PROVE INACCURATE, WE MAY NEED TO ADJUST OUR STRATEGIC TIMELINE OR RESOURCE ALLOCATION,WHILE WE BELIEVE THESE PATENTS PROVIDE MEANINGFUL
PROTECTION FOR CERTAIN ASPECTS OF OUR TECHNOLOGY, THERE IS NO GUARANTEE THAT THEY WILL PREVENT ALL COMPETITORS FROM DEVELOPING SIMILAR
PRODUCTS, FAILURE TO COMPLY WITH THE FAMILY EDUCATIONAL RIGHTS AND PRIVACY ACT ("FERPA") COULD LIMIT OR DELAY OUR ABILITY
TO DEPLOY SAFESCHOOL IN CERTAIN JURISDICTIONS, IMPACT CUSTOMER ADOPTION, OR EXPOSE THE COMPANY TO REGULATORY RISK AND OTHER FACTORS
INCLUDE, AMONG OTHERS, THOSE LISTED UNDER "FORWARD-LOOKING STATEMENTS" AND "RISK FACTORS" AND THOSE INCLUDED
ELSEWHERE IN THIS REPORT.

 Overview

Global Corporation (collectively the "Company," "we," "our" or "us") is a multimodal
AI technology solutions company with a dedicated team focused on driving safety innovation across multiple industries. We are currently
marketing products and solutions that utilize advanced AI tools to monitor and enhance resident safety, reduce the risk of injuries,
and improve overall care efficiency.

 In
April 2025, we completed a strategic rebranding initiative, adopted our current corporate name SafeSpace Global Corporation, and transitioned
to the trading symbol "SSGC" for our common stock. These changes reflect our expanded mission to deliver life-saving multimodal AI technology solutions across a wide range of environments beyond healthcare, including schools, transit systems, correctional
facilities, and commercial infrastructure. With operations spanning the United States, Europe, Singapore, and India, our branding supports
SafeSpace's evolution into a technology-driven global enterprise dedicated to protecting lives wherever people live, learn, travel,
or work. We believe that this transformation strengthens our market positioning and aligns our corporate identity with our broadened
strategic vision.

 We
market the following products and solutions, including our initial product, SafeSpace Fall Monitoring, which utilizes advanced AI
monitoring tools to enhance resident safety in senior living, reduce the risk of injuries, and improve overall care efficiency. Additionally,
we have expanded our services and offerings beyond senior living facilities, into schools and transportation where we've recently
launched these innovative solutions:

 SafeFace
 Access Control – An advanced solution that leverages facial recognition to automatically
 and instantly unlock doors for registered staff and visitors, integrating seamlessly with
 an existing maglock system for a completely keyless and no badge entry.

 SafeFace
 Time Compliance – A platform that monitors staff movements, rounds, and care tasks
 in real time, delivering actionable insights to leadership. These insights enable more informed
 decision-making and help streamline daily operations.

 SafeGuard
 Wander Protection – Strategically-placed facial recognition cameras that trigger
 alerts when an at-risk resident is seen outside a secured unit, reducing immediate jeopardy
 situations and litigation.

 SafeTrace
 Rapid Investigations – An innovative investigation solution—simply select
 a face to instantly retrieve video clips of that individual across facilities, anytime. Local
 data storage ensures security and cost efficiency, saving countless hours in investigations.

 SafeSchool
 – Designed to address growing concerns around school safety by proactively detecting
 weapons and identifying persons of concern through real-time AI-based monitoring. The SafeSchool
 multimodal AI solution is designed to help protect students during school hours while
 offering peace of mind to guardians. The SafeSchool product offers proactive protection
 that cameras on their own cannot provide. Our software proactively alerts when weapons are
 detected or persons of concern (i.e. predators or non-custodial parents) are sighted, offering
 immediate situational awareness to deter a tragedy. We are actively working with external
 advisors, school administrators, and legal counsel to ensure that SafeSchool is deployed
 in a FERPA-compliant manner. We view FERPA compliance as a priority and are committed to
 aligning the SafeSchool offering with applicable privacy laws.

 Strategy

Global Corporation is executing a focused growth strategy led by a world-class team of executives with deep experience in scaling innovative
companies. Our leadership team combines proven operational expertise with a mission-driven commitment to safety and impact. Our primary
objective is to expand the adoption of our life-saving multimodal AI technology across both existing and emerging verticals.
These include senior living, education, transportation, and corrections—with future expansion planned into commercial infrastructure
and high-risk institutional settings. To support this growth, we have strengthened our development team with senior IT architects, AI
specialists, and systems engineers who are accelerating product innovation and market deployment on a global scale. A key pillar of this
strategy is our dedicated sales force, which brings both deep domain knowledge and a shared commitment to leveraging AI to save
lives. This integrated team is actively driving customer engagement, market penetration, and adoption of our multimodal safety solutions
across diverse environments.

and Operating Results

 As
of the date of this filing, the Company has approximately $6,500,000 in cash and cash equivalents from recent private placements. Management
believes this adequately supports the Company's five-year strategic plan enabling strategic initiatives, such as acquisitions,
investments in advanced AI technology, and the expansion of its technology development team. SafeSpace Global Corporation remains committed
to driving innovation in healthcare technology, with a focus on solutions that enhance safety, efficiency, and patient outcomes across
various care settings.

 Highlighted
achievements for the twelve months ending July 31, 2025 include:

 On
 August 23, 2024, we appointed Micheal "Coach" Burt to our Board of Directors.

 On
 October 1, 2024, we appointed Timothy R. Brady as Fractional Chief Financial Officer and on December 1, 2024, appointed him to full-time
 Chief Financial Officer.

 On
 November 5, 2024, we announced the appointment of Caleb Dixon as Chief Customer Officer to focus on enhancing customer engagement
 and satisfaction. Mr. Dixon's title was recently changed to Director of Customer Success.

 On
 December 9, 2024, we announced the appointment of Theo Davies as Vice President of Sales Enablement & International Expansion
 and on April 17, 2025, we announced that Theo Davies was appointed as our new Chief Revenue Officer (CRO).

 On
 December 18, 2024, we announced the engagement of Katie Piperata as a Senior Living Consultant for the Company's Healthcare
 division.

 On
 December 30, 2024, we announced the promotion of Dustin Hillis to President and Chief Strategy Officer.

 On
 January 7, 2025, we announced that Justin Freishtat joined in a capital advisory role with Investor Relations.

 On
 March 14, 2025, we appointed Anthony Chapman to our Board of Directors.

 On
 April 10, 2025, we announced that Anand Ijju joined as our Chief Technology Officer (CTO).

 On
 April 15, 2025, we announced that Sasidhar Valluru was appointed as our Director of Global
 Product Delivery.

 On
 April 15, 2025, we appointed FKP Advisors LLC, as a non-independent member, to the Board
 of Directors. FKP Advisors LLC board seat will be on a rotational basis with Larry Kloess
 III serving in the first year, followed by Jim Fitzgerald in the second year, and Ben Pope
 in the third year.

 On
 June 26, 2025, we announced a strategic test pilot program with the Kansas City Area Transportation
 Authority in preparation for the FIFA World Cup 2026.

 On
 July 7, 2025, we announced the appointment of Katie Piperata as our new Vice President of
 Senior Living.

 We
 received $10,764,700 in net proceeds from the sale of our common stock at an average price of $0.116 per share during the twleve months
 ending July 31, 2025.

 Results
of Operations

 Revenues

 We
had no Contract revenue or Cost of contracts during the year ended July 31, 2025. During the year ended July 31, 2024, we recognized
$322,000 in Contract revenue and $239,948 in Cost of contracts.

 Operating
Expenses

 The
table below presents a comparison of our operating expenses for the years ended July 31, 2025 and 2024:

 For
 the Years Ended
 July 31,

 2025

 2024

 $
 Change

 %Change

 Executive compensation

 $
 679,061

 $
 359,942

 $
 319,119

 %

 Salaries and wages

 166,882

 -

 166,882

 -

 Bonuses and incentives

 145,395

 -

 145,395

 -

 Contract labor

 216,596

 -

 216,596

 -

 Professional fees

 544,516

 64,556

 479,960

 %

 Insurance

 75,332

 -

 75,332

 -

 Software development

 157,327

 40,805

 116,522

 %

 Sales support

 64,006

 -

 64,006

 -

 Travel and entertainment

 270,940

 25,709

 245,231

 %

 Advertising and marketing

 244,313

 9,919

 234,394

 2363
 %

 Rent expense

 77,006

 -

 77,006

 -

 Office expense

 87,308

 7,051

 80,257

 1138
 %

 Other

 27,544

 8,298

 19,246

 %

 Total Selling, general
 & administrative

 2,756,226

 516,280

 2,239,946

 %

 Stock-based compensation

 1,575,211

 186,643

 1,388,568

 %

 421,955

 221,919

 200,036

 %

 Impairment of intangibles

 46,225

 140,770

 (94,545
)

 (67
)

 Total
 Operating Expenses

 $
 4,799,617

 $
 1,065,612

 $
 3,734,005

 %

 Officers'
Compensation - Officers' compensation increased $319,119, or 89%, over the prior period primarily due to the addition of the
President & Chief Strategy Officer, increased pay for the Chief Financial Officer and Chief Executive Officer compared to the previous
period and the addition of our Chief Revenue Officer. Additionally, the Company's officers accepted voluntary pay reductions in
the prior comparable period.

 Salaries
and wages – Salaries and wages increased $166,882 over the prior period and is attributable to the addition of new finance,
accounting and administrative personnel.

 Bonuses
and incentives – Bonuses and incentives increased $145,395 over the prior period and is attributable to bonuses and incentive
payments for the addition of new officers and personal.

labor – Contract labor increased $216,596 over the prior period and is attributable to the addition of new finance, accounting
and administrative personnel.

 Professional
Fees - Professional fees increased $479,960, or 743% over the same period in the prior year primarily due to increased legal, accounting,
and IT support fees and the addition of a grant writing consultant.

 Insurance
 – Insurance expense increased $75,332 over the prior period and is attributable to no insurance expenses in the prior comparable
period, due to the addition of health, dental and business insurance.

 Software
Development – Software development expenses increased $116,522, or 286% over the same period in the prior year due to an increase
in the use of independent contractors and consultants for specific development projects.

 Sales
support – Sales support expense increased $64,006 over the prior period and is attributable to no sales support expenses
during the prior comparable period.

 Travel
and entertainment – Travel and entertainment expense increased $245,231, or 954% over the same period in the prior year. The increase
is primarily due to increased business travel.

 Advertising
and Marketing - Advertising and marketing costs increased $234,394, or 2,363% over the same period in the prior year due to increased
promotional activities.

 Rent
expense – Rent expense increased $77,006 over the same period in the prior year due to no rent expense in the prior year.

 Office
expense - Office expense increased $80,257, or 1,138% primarily due to increases in office expense activity over the same period in the prior
year.

 Other
 - Other expenses increased $19,246, or 232% over the same period in the prior year primarily due to limited activity over the same period
in the prior year.

Compensation - Stock-based compensation expense increased $1,388,568, or 744% from the same period in the prior year. The increase results
from the amortization of the grant date fair value of new restricted stock awards.

 - Amortization expenses increased $200,036, or 90% over the same period in the prior year, primarily due to a reduction in the estimated
useful life from three years to two years of software development costs.

of Intangibles - Impairment of intangibles decreased $94,545, or 67% over the same period in the prior year. The impairment expense relates
to the abandonment of certain patent applications and the establishment of an impairment reserve on active patent applications.

 Other
Income (Expense)

 The
table below presents a comparison of our other income (expense) for the years ended July 31, 2025 and 2024:

 For
 the Years Ended
 July
 31,

 2025

 2024

 $
 Change

 %Change

 Interest income

 $
 85,909

 $
 -

 $
 85,909

 -

 Interest expense

 (38,509
)

 (55,079
)

 16,570

 %

 Extinguishment of liabilities

 113,645

 279,903

 (166,258
)

 (59
)%

 Gain on settlements

 -

 56,250

 (56,250
)

 -

 Total
 Other Income (Expense)

 $
 161,045

 $
 281,074

 $
 (120,029
)

 (43
)%

 Interest
income - Interest income increased $85,909 for fiscal 2025, resulting from interest earned from our outstanding cash balances. We
had no interest income in fiscal 2024.

 Interest
Expense - Interest expense decreased $16,570, or 30%, over the prior year. Interest expense decreased due to the payoff of all outstanding
debt.

 Extinguishment
of Liabilities – Extinguishment of liabilities decreased $166,258, or 59% compared to the prior year. In 2024 the company recorded
an extinguishment of liabilities of $279,903 as management determined it was more likely than not that the Company would not be required
to settle the obligations, which were recorded on the books of a non-operating subsidiary offset. In 2025, the company recorded income
of $113,645 as holders exchanged 5% Convertible Promissory Notes plus accrued interest through the conversion date at a conversion price
of $0.50 per share, the settlement of the Note Payable to Acorn Management Partners offset by a loss for the unamortized issuance costs
from the extinguishment of the Platinum Note.

 Gain
on Settlements – In the prior year we recorded a gain on settlements of $56,250 upon the settlement amounts owed to a consultant
that were expensed in a prior year. We had no gain on settlements in 2025.

 Liquidity
and Capital Resources

 Working
Capital

 The
following table summarizes our working capital for the fiscal year ended July 31, 2025 and fiscal year ended July 31, 2024:

 July

 July

 Current assets

 $
 7,640,434

 $
 222,584

 Current liabilities

 (366,011
)

 (1,022,522
)

 Working capital surplus
 (deficiency)

 $
 7,274,432

 $
 (799,938
)

 Current
assets for the period ending July 31, 2025 changed $7,417,850 as compared to the fiscal year ended July 31, 2024. The increase is primarily
due to the receipt of $10,764,700 in net proceeds from the sale of our common stock at an average price of $0.116 per share for the period
ending July 31, 2025.

 Current
liabilities for the period ending July 31, 2025 decreased $656,511 as compared to the fiscal year ended July 31, 2024. The decrease is
primarily due to decreases in accounts payable and accrued expenses and a reduction in the Notes payable and Notes payable, related party.

 Net
Cash Used by Operating Activities

 We
currently do not have a revenue source and will continue to have negative cash flow from operations for the near future. The factors
in determining operating cash flows are largely the same as those that affect net earnings, except for non-cash expenses such as depreciation
and amortization, stock-based compensation, and impairment of intangibles, which affect earnings but do not affect operating cash flow.
Net cash used by operating activities was $2,676,309 for the period ending July 31, 2025, as compared to net cash used by operating activities
of $267,729 for the comparable prior period. The increase in cash used by operating activities is primarily attributable to an increase
in operating costs and the payment of accounts payable and accrued expenses, related party items.

 Net
Cash Used by Investing Activities

 Net
cash used by investing activities for the development of software for our internal use was $175,747 for the period ending July 31,
2025. We did not incur net cash used in investing activities during the comparable prior period. management anticipates
approximately $500,000 in capitalized software development costs during next fiscal year to support ongoing product
innovation.

 Net
Cash Provided by Financing Activities

 Net
cash provided by financing activities was $10,222,884 for the period ending July 31, 2025, which represents a $9,780,004 increase over
the same period in the prior year. The increase is primarily due to the receipt of $10,764,700 in net proceeds from the sale of our common
stock at an average price of $0.116 per share offset by payments of amounts owed to related parties.

 Critical
Accounting Policies and Estimates

 Our consolidated financial statements and related public financial information are based on the application of U.S. GAAP. U.S. GAAP
requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on
the assets, liabilities, revenues and expense amounts reported. These estimates can also affect supplemental information contained in
our external disclosures including information regarding contingencies, risk and financial condition. We believe our use of estimates
and underlying accounting assumptions adhere to U.S. GAAP and are consistently and conservatively applied. We base our estimates on historical
experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially
from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation
of our financial statements.

 Our
significant accounting policies are summarized in Note 1 of our consolidated financial statements.

 We
believe the following critical policies impact our more significant judgments and estimates used in preparation of our consolidated
financial statements.

 Business
Combinations

 We
account for business combinations under the acquisition method of accounting. The acquisition method requires that the acquired assets
and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and that changes thereafter be
reflected in income (loss). The estimation of fair values of the assets and liabilities assumed involves several estimates and assumptions
that could differ materially from the actual amounts recorded. The results of the acquired businesses are included in our results from
operations beginning from the day of acquisition.

 Risk
and Uncertainties

 Factors
that could affect our future operating results and cause actual results to vary materially from management's expectation include,
but are not limited to: our ability to maintain and secure adequate capital to fund our operations and fully develop our product(s);
our ability to source strong opportunities with sufficient risk adjusted returns; acceptance of the terms and conditions of our licenses
and/or the acceptance of our royalties and fees; the nature and extent of competition from other companies that may reduce market share
and create pressure on pricing and investment return expectations; changes in the projects in which we plan to invest which result from
factors beyond our control, including, but not limited to, a change in circumstances, capacity and economic impacts; changes in laws,
regulations, accounting, taxation, and other requirements affecting our operations and business. Negative developments in these or other
risk factors could have a significant adverse effect on our financial position, results of operations and cash flows.

 Use
of Estimates

 The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. We base our estimates on experience and various other assumptions that are believed to be reasonable under the circumstances.
We evaluate our estimates and assumptions on a regular basis and actual results may differ from those estimates.

 Fair
Value of Financial Instruments

 Fair
value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between
market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices
in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as
follows:

 Level
1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the
measurement date.

 Level
2 Inputs - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets
or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (such as
interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated by market
data by correlation or other means.

 Level
3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions
about the assumptions that market participants would use in pricing the assets or liabilities.

instruments consist of cash and cash equivalents, accounts receivable, accounts payable and borrowings. The fair value of current financial
assets and current financial liabilities approximates their carrying value because of the short-term maturity of these financial instruments.

 Intangible
Assets

 Intangible
assets consist of patents, our website, and the costs of software developed for internal use. Certain payroll and stock-based compensation
costs incurred are allocated to the intangible assets. We determine the amount of costs to be capitalized based on the time spent by
employees or outside contractors on the projects. Intangible assets are amortized over their expected useful life on a straight-line
basis. We evaluate the useful lives of these assets on an annual basis and test for impairment whenever events or changes in circumstances
occur that could impact the recoverability of these assets. If the estimate of an intangible asset's remaining life is changed,
the remaining carrying value of the intangible asset is amortized prospectively over the revised remaining useful life.

of Long-Lived Assets

 Long-lived
assets such as property, equipment, and identifiable intangibles are reviewed for impairment at least annually or whenever facts and circumstances
indicate that the carrying value may not be recoverable. When required, impairment losses on assets to be held and used are recognized
based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets,
if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable, an impairment
loss is recognized for the difference between the carrying amount and fair value of the asset.

 Derivative
Liability

 Options,
warrants, convertible notes, or other contracts, if any, are evaluated to determine if those contracts, or embedded components of those
contracts, qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board ("FASB")
Accounting Standards Codification ("ASC") Topic 815, "Derivatives and Hedging," (paragraph 815-10-05-4
and Section 815-40-25). The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market
each balance sheet date and recorded as either an asset or a liability. The change in fair value is recorded in the consolidated statements
of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked
to fair value at the date of conversion, exercise, or cancellation and then the related fair value is reclassified to equity.

 In
circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated, and there are also other
embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments
are accounted for as a single, compound derivative instrument.

 The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification
are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will
be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument
is expected within 12 months of the balance sheet date.

 The
Company adopted Section 815-40-15 of the FASB ASC ("Section 815-40-15") to determine whether an instrument (or an
embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two- step approach
to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the
instrument's contingent exercise and settlement provisions.

 We
utilize a binomial option pricing model to compute the fair value of the derivative liability and to mark to market the fair value of
the derivative at each balance sheet date. We record the change in the fair value of the derivative as other income or expense in the
consolidated statements of operations.

 Related
Parties

 The
Company follows subtopic ASC 850-10 for the identification of related parties and disclosure of related party transactions. Pursuant
to Section 850-10-20, the related parties include: (a) affiliates of the Company ("Affiliate" means, with respect to any
specified person, any other person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is
under common control with such person, as such terms are used in and construed under Rule 405 under the Securities Act); (b) entities
for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value
Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit
of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners
of the Company; (e) management of the Company; (f) other parties with which the Company may deal if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from
fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies
of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other
to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

Liabilities

 The
Company receives payments from customers based upon contractual billing schedules. Contract liabilities include payments received in
advance of performance under the contract. Contract assets include amounts related to the Company's contractual right to consideration
for completed performance obligations not yet invoiced. Our contract assets and liabilities are reported on an individual contract basis
at the end of each reporting period. Contract liabilities are classified as current or noncurrent based on the timing of when we expect
to recognize revenue. The Company expects to recognize all outstanding contract liabilities over the next 12 months.

Combination

 The
Company may execute more than one contract or agreement with a single customer. The Company evaluates whether the agreements were negotiated
as a package with a single objective, whether the amount of consideration to be paid in one agreement depends on the price and/or performance
of another agreement, or whether the goods or services promised in the agreements represent a single performance obligation. The conclusions
reached can impact the allocation of the transaction price to each performance obligation and the timing of revenue recognition related
to those arrangements. The Company applied the revenue model to a portfolio of contracts with similar characteristics where we expected
that the financial statements would not differ materially from applying it to the individual contracts within that portfolio.

 Revenue
Recognition

 Revenue
is recognized under ASC 606, " Revenue from Contracts with Customers " using the modified retrospective method. Under
this method, the Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following manner:
1) Identify the contract; 2) Identify the performance obligations of the contract; 3) Determine the transaction price of the contract;
4) Allocate the transaction price to the performance obligations; and 5) Recognize revenue. An entity recognizes revenue for the transfer
of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in
exchange for those goods or services. The Company's revenue recognition policies remained unchanged as a result of the adoption
of ASC 606, and there were no significant changes in business processes or systems.

 Stock-Based

 The
Company accounts for stock-based compensation in accordance with ASC Topic 718, " Compensation – Stock Compensation"
 ("ASC 718") which establishes financial accounting and reporting standards for stock-based employee compensation. It
defines a fair value-based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation
cost for stock option plans, if any, in accordance with ASC 718.

payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of stock-based payment awards issued
to non-employees for services rendered have been recorded at the fair value of the stock-based payment, which is the more readily determinable
value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If
an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the
termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses,
depending on the nature of the services provided, in the consolidated statements of operations. Stock-based payments issued to placement
agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital.

 The
Company recognizes all forms of stock-based payments, including stock option grants, warrants and restricted stock grants, at their fair
value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.

 Capital
Resources

 We
had no material commitments for capital expenditures as of July 31, 2025.

 Off-Balance
Sheet Arrangements

 The
Company has no off-balance sheet arrangements as of July 31, 2025.

 ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 We
do not hold any market risk sensitive instruments. At July 31, 2025, there was no floating rate debt that would expose us to market fluctuations
in interest rates.

 ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 The
financial statements and supplementary financial information required to be filed under this Item 8 are presented in Part IV, Item 15
of this Form 10-K and are incorporated herein by reference.

 ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 None.

 ITEM
9A. CONTROLS AND PROCEDURES.

 Disclosure
Controls and Procedures

 Under
the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer,
we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in
Rules 13a-15(e) under the Securities Exchange Act of 1934, as amended, at the end of the period covered by this report (the "Evaluation
Date").

 Based
on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date we did maintain
disclosure controls and procedures that were effective in providing reasonable assurances that information required to be disclosed in
our reports filed under the Securities Exchange act of 1934 was recorded, processed, summarized, and reported within the time periods
prescribed by SEC rules and regulations, and that such information was accumulated and communicated to our management to allow timely
decisions regarding required disclosure.

 Our
management, including the Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures
will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute,
assurance that the control system's objectives will be met. Further, the design of a control system must reflect the fact that
there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations
in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any,
have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns
can occur because of simple error or mistake. The design of any system of controls is based in part upon certain assumptions about the
likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential
future conditions.

 Management's
Report on Internal Control over Financial Reporting

 Our
management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f)
under the Exchange Act). Our management assessed the effectiveness of our internal control over financial reporting as of July 31, 2025.
Based on the evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of July 31, 2025, our internal controls
over financial reporting were not effective.

 In
making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway
Commission in Internal Control-Integrated Framework. Our management has concluded that, as of July 31, 2025, our internal control
over financial reporting is not effective based on these criteria. Management identified a material weakness related to the
concentration of control in a single individual without adequate compensating controls overseeing the approval of the procurement
and expense reimbursement process. Management is in the process of developing and implementing controls in place to mitigate
those risks going forward. This annual report does not include an attestation report of our registered public accounting firm
regarding internal control over financial reporting. Management's report was not subject to attestation by our registered
public accounting firm pursuant to temporary rules of the SEC that permit us to provide only management's report in this
annual report.

 Changes
in Internal Control over Financial Reporting

 Except for the remediation of
previously identified material weaknesses, there were no changes in our internal control over financial reporting during our most
recently completed fourth quarter of the fiscal year end that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.

 ITEM
9B. OTHER INFORMATION

 None
of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction
or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)
of the Exchange Act or any non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the fiscal quarter
ended July 31, 2025.

 PART
III

 ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 The
following table sets forth information concerning our officers and directors as of the dates indicated. The directors of the Company
serve until their successors are elected and shall qualify. Executive officers are elected by the Board of Directors and serve at the
discretion of the directors.

 Name

 Age

 Title

 Scott
 M. Boruff

 Chief
 Executive Officer, Chairperson, Director

 Timothy
 R. Brady

 Chief
 Financial Officer

 Dustin
 M. Hillis

 President
 and Chief Strategy Officer

 Theo
 Davies

 Chief
 Revenue Officer

 Anand
 Ijju

 Chief
 Technology Officer

 Susan
 A. Reyes

 Chief
 Medical Officer

 G.
 Shayne Bench

 Anthony
 Chapman

 Micheal
 J. Burt

 Larry
 Kloess III

 Set
forth below is a brief description of the background and business experience of each of our current executive officers and directors.

 Scott
M. Boruff, Chief Executive Officer, Chairperson, Director, Age 62

 Mr.
Boruff has served as our Chief Executive Officer and Sole Director since 2018. Since May 2021, he has served as an outsourced, contracted
Chief Executive Officer and Director. He has been the sole officer and director of IndeLiving Holdings, Inc., since the Company's
formation in 2016. Mr. Boruff has also served as the Manager of Platinum Equity Advisors, LLC ("Platinum Equity") since its
formation in 2016. In addition to providing consulting and advisory services, Platinum Equity has interests in a real estate brokerage
firm and a luxury real estate auction firm. Mr. Boruff is a proven executive with a diverse business background in investment banking
and real estate development. He currently serves as Manager of Own Shares, LLC, a privately held holding company with interests in various
entertainment ventures, and Managing Member of Stonewalk Companies, a privately held real estate development company. As a professional
in investment banking, he specialized in consulting services and strategic planning with an emphasis on companies in the oil and gas
field. Mr. Boruff served as a member of the Board of Directors of Miller Energy Resources, Inc., a publicly traded company, from August
2008 until March 2016, serving as Executive Chairman of the Board of Directors from September 2014 until March 2016 and Chief Executive
Officer from August 2008 to September 2014. In October 2015, when it was being led by a successor management team, Miller Energy Resources,
Inc. filed a voluntary petition for reorganization under chapter 11 of title 11 of the U.S. Code in a pre-packaged bankruptcy. It remained
a debtor in possession and emerged from bankruptcy in March 2016. Mr. Boruff was a director and 49% owner of Dimirak Securities Corporation,
a broker-dealer and member of FINRA, from April 2009 until July 2012. In July 2012, Mr. Boruff sold his interest in Dimirak. He has more
than 30 years of experience in developing commercial real estate projects and from 2006 to 2007 Mr. Boruff successfully led transactions
averaging $150 to $200 million in size while serving as a director of Cresta Capital Strategies, LLC. Mr. Boruff received a Bachelor
of Science degree in Business Administration from East Tennessee State University.

 Timothy
R. Brady, Chief Financial Officer, Age 63

 Timothy
Brady has served as our Chief Financial Officer ("CFO") since October 1, 2024. Mr. Brady previously served as CFO and Treasurer
of Northern Industrial Sands, LLC, a privately held supplier of northern white frac sand, from July 2016 to August 2020. In addition,
Mr. Brady previously served as CFO and Treasurer of Dakota Plains Holdings, Inc., a publicly traded midstream energy company, from September
2011 to April 2016. Mr. Brady was instrumental in uplisting the Company from the OTC Pink Sheets to the NYSE. Before joining Dakota Plains,
Mr. Brady served as one of three founders and CFO of Encore Energy, a privately held independent operator of oil and natural gas properties,
from May 2011 through September 2011. Prior to that position, Mr. Brady served as the CFO from April 2010 through May 2011 of Allied
Energy Inc., a publicly traded oil and natural gas company, and served on its board of directors, where Mr. Brady was able to upgrade
the firm to the highest grading level on the OTC Market tier. Prior to that position, Mr. Brady was an independent consultant for eight
years. Mr. Brady has over 40 years of financial experience within the energy, financial services, and manufacturing industry. Mr. Brady
has experience with SEC reporting, balance sheet management, investor relations, treasury, mergers and acquisitions, audit, internal
controls implementation, and compliance. Mr. Brady holds a Bachelor of Science degree in Finance from Indiana University and an MBA from
Loyola University of Chicago.

 Dustin
M. Hillis, President and Chief Strategy Officer, Age 43

 Dustin
M. Hillis has served as our Chief Strategy Officer since June 15, 2024. On December 30, 2024, Mr. Hillis was promoted to President and
continued to act as our Chief Strategy Officer. Mr. Hillis brings a wealth of experience and a proven history of success to the Company.
Prior to joining our executive team, Mr. Hillis was the CEO of a global conglomerate, managing and expanding 20 diverse international
businesses, with a workforce of over 2,000 individuals worldwide. His career spanned two decades within the family of companies. Mr.
Hillis' multifaceted expertise in leadership, strategic growth, and operational excellence has been recognized through numerous
accolades, including being named a "Top 10 CEO" by Industry Era and one of the "Top 50 Consulting CEOs" by the
Consulting Report. In addition to his corporate accomplishments, Mr. Hillis is an Amazon 'Best Selling Author,' an international
real estate investor, as well as a sought-after keynote speaker who has delivered addresses across the globe. His broad influence and
insights across various industries have been pivotal to his career success.

 Theo
Davies, Chief Revenue Officer, Age 45

 Theo
Davies has served as our Chief Revenue Officer since April 17, 2025. Mr. Davies was a former Google executive, who was the Head of Sales
Enablement for Asia-Pacific. Mr. Davies brings a wealth of global expertise and leadership to SafeSpace Global. His exceptional background,
including a master's in mathematics, from the University of Edinburgh and an MBA from India's top business school, SP Jain,
Mr. Davies has consistently demonstrated his ability to develop world-class business strategies, build high-performing teams, and drive
groundbreaking innovation within the Company's international business.

 Anand
Ijju, Chief Technology Officer, Age 58

 Anand
Ijju has served as our Chief Technology Officer since April 10, 2025. Prior to joining SafeSpace Global, Mr. Ijju was the Executive Vice
President of ProKarma (Concentrix), a global IT solutions
company, where he was instrumental in scaling the business to over half a billion dollars in revenue, before its successful exit. ProKarma's
revenue at the time of sale to Concentrix was $525 million, with a valuation of approximately $1.5 billion. Over
the past two decades, Mr. Ijju has held executive technology leadership roles in high-growth companies, driving innovation across AI,
data engineering, and scalable cloud infrastructure. His ability to turn vision into world-class products positions SafeSpace Global Corporation for explosive growth.

 Susan
A. Reyes, M.D., Chief Medical Officer, Age 62

 Susan
A. Reyes, M.D. has served as our Chief Medical Officer since September 1, 2020. Dr. Reyes brings experience as a practicing Internal
Medicine physician in the home care environment. She earned her Doctor of Medicine degree in just six years and was board certified in
Internal Medicine in 1994. Since then, Dr. Reyes has enjoyed expanding her skill set by collaborating with several ground-breaking companies.
In 1997, she worked for Hospital Inpatient Management Systems, which was the first hospitalist group that transformed the efficiencies
of "length of stay" of patients in the hospital and in skilled nursing facility settings. In 2000, she was the lead physician
for MD to You in Tampa, Florida - the first organization that developed house calls for homebound geriatric patients. In 2009, Dr. Reyes
became the first physician to bring house call services to Knoxville, Tennessee and has grown her Company to be the largest mobile medical
primary care practice covering East Tennessee. She has been an advisor and served as Medical Director to several home health and hospice
agencies and assisted living facilities in each community where she has resided.

 G.
Shayne Bench, Independent Director – Audit Committee Chair, Age 52

 G.
 S hayne Bench has served as a Director since September 8, 2022 and is co-founder and Chief Financial Officer of Trillium Healthcare
Consulting. Mr. Bench began his professional career in 1994 with Beverly Enterprises where he held various leadership roles, including
Vice President of Finance for all 53 Skilled Nursing Facilities in the state of Florida. In 2001, Mr. Bench joined an executive team
to start up Genoa Healthcare Group. As Senior Vice President and Treasurer, he successfully managed the cash flow while the organization
grew to 135 Skilled Nursing Facilities in 17 states with nearly one billion dollars in revenue. He managed all aspects of strategic capitalization,
established creditor and banking relationships, and managed financial reporting to investors. Mr. Bench is originally from Louisiana
and received his Bachelor of Science in Business Administration with a major in accounting from Northeastern State University.

 Anthony
Chapman, Independent Director – Nominating Committee, Age 66

 Anthony
Chapman is an Independent Director and Chair of our Nominating Committee. Mr. Chapman, a former Special Operations Intelligence Officer
and founding member of one of the most classified divisions
in Joint Special Forces, brings decades of elite military, security, and strategic consulting experience to the company's leadership
team. Mr. Chapman is a decorated American hero with a career spanning over 40 years, including pivotal roles in military intelligence,
corporate security, and executive leadership. As the President of Chapman Consulting Group, since 2001, Mr. Chapman has built and led
a global consulting business, employing hundreds of elite former special operations team members to support U.S. allies worldwide.

 Micheal
J. Burt, Independent Director – Compensation Committee, Age 49

 Micheal
J. Burt has served as an Independent Director since August 23, 2024. Micheal "Coach" Burt is recognized as the unparalleled
authority in awakening the Prey Drive within individuals and guiding them to unparalleled accomplishments. With a career spanning over
three decades, Coach Burt has solidified his reputation for transformative coaching excellence across a spectrum of industries. As the
Founder of The Greatness Factory in Nashville, Tennessee, Coach Burt has elevated his coaching philosophy to an art form. His approach
goes beyond conventional motivation, delving deep into the intricacies of activating the Prey Drive - an insatiable pursuit of excellence
that propels individuals to achieve their goals with unwavering determination. With a storied history of cultivating top performers,
Coach Burt empowers individuals to not only tap into their unique brilliance but also to translate it into thriving ventures. His methodologies
offer a proven blueprint for turning ideas into tangible success. Coach Burt is the author of "Flip the Switch," which is
a must-read for anyone looking to take their personal and professional growth to the next level. Mr. Burt currently resides in Nashville,
Tennessee.

 Larry
Kloess, Director, Age 70

 Lawrence
('Larry') H. Kloess III has served as our board member as of April 15, 2025. Mr. Kloess is a retired hospital CEO with 30
years of service at HCA, including his tenure as CEO of HCA's flagship hospital, TriStar Centennial Medical Center, from 1998-2005,
and then President of HCA's TriStar Division from 2005-2012. TriStar is HCA's largest division of 22 hospitals serving communities
in TN, KY, and GA. After retiring from HCA in 2012, Larry joined Clayton Associates, a Nashville-based venture capital firm; becoming
the firm's Chairman in 2015. He subsequently founded a healthcare consulting firm in Nashville ("FKP Advisors") while
serving on the Advisory Boards of FCA Venture Partners and Altitude Ventures. From 2016 to 2025, Larry served on the Belmont University
Board of Trustees as Chair of the Board's Finance Committee. Larry is a founding Board member of Shore Capital Partners'
portfolio company, EyeSouth Partners, based in Atlanta. Larry also actively supports a number of Christian charities, including the Men
of Valor prison ministry, where he served as its Treasurer and Board Chairman for many years. Larry also served as Chairman of the Board
for the Tennessee Hospital Association in 2011, and received the "Hero of Business Award" from Lipscomb University's
College of Business in 2016. Larry earned his bachelor's degree in Healthcare Management from the University of Alabama, and his
master's degree in Hospital and Health Administration from Xavier University in Cincinnati. He is a Fellow in the American College
of Healthcare Executives.

 Family
Relationships

 There
are no family relationships among any of our directors or executive officers.

 Involvement
in Certain Legal Proceedings

 To
the best of the Company's knowledge, none of the Company's directors or executive officers has, during the past ten years,
except as set forth below:

 been
 convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor
 offenses);

 had
 any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business
 association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years
 prior to that time;

 been
 the subject of any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction
 or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, involvement in any
 type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated
 with persons engaged in any such activity;

 been
 found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated
 a federal or state securities or commodities law, and the judgment in such civil action has not been reversed, suspended, or vacated;

 been
 the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently
 reversed, suspended or vacated, relating to (i) an alleged violation of any federal or state securities or commodities law or regulation,
 (ii) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or
 permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order,
 or removal or prohibition order, or (iii) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business
 entity; or

 been
 the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization
 (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange
 Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons
 associated with a member.

 Mr.
Boruff served as a member of the Board of Directors, as Chief Executive Officer, and as Executive Chairman of Miller Energy Resources,
Inc. during the two years preceding Miller Energy Resources, Inc.'s filing of a bankruptcy petition in August 2015.

 Except
as set forth in the Company's discussion below in "Certain Relationships and Related Transactions, and Director Independence",
none of the Company's directors or executive officers has been involved in any transactions with the Company or any of the Company's
directors, executive officers, affiliates, or associates which are required to be disclosed pursuant to the rules and regulations of
the Commission.

 Delinquent
Section 16(a) Reports

 Section
16(a) of the Exchange Act requires the Company's directors, executive officers and persons who beneficially own 10% or more of
a class of securities registered under Section 12 of the Exchange Act to file reports of beneficial ownership and changes in beneficial
ownership with the SEC. Directors, executive officers and greater than 10% stockholders are required by the rules and regulations of
the SEC to furnish the Company with copies of all reports filed by them in compliance with Section 16(a).

 Based
solely on our review of certain reports filed with the Securities and Exchange Commission pursuant to Section 16(a) of the Exchange Act, as amended, the reports required to be filed with respect to transactions in our common stock during fiscal 2025 were timely filed other than one late report for Micheal J. Burt regarding a share award in connection
with his commencement of service in August 2024; two late reports for Timothy R. Brady regarding the commencement of his service as a
reporting person and an award of fully vested stock in December and October 2024, respectively; and three late reports for Dustin M. Hillis
regarding a restricted stock award in October 2024, and purchases of shares from the Company in October 2024 and February 2024. Additionally,
each of Anthony Chapman, and Theo Davies, Anand Ijju, and Larry Kloess III have not yet filed a Form 3 reporting their commencement of
service as reporting persons as of March 14, 2025, April 17, 2025, May 1, 2025, and April 14, 2025, respectively. Mr. Ijju has not yet
reported an award of restricted stock received on May 1, 2025 and Mr. Davies has not yet reported an award of fully vested stock received
as of April 17, 2025.

 Code
of Ethics

 The
Company does not currently have a code of ethics, and because the Company has only limited business operations and only six officers
and four directors, the Company believes that a code of ethics would have limited utility. The Company intends to adopt such a code of
ethics as the Company's business operations expand and the Company has more employees and operations.

 Insider
Trading Policy

 We
have adopted an insider trading policy that governs the purchase, sale, and other dispositions and transactions in our securities by
our directors, officers and employees, which is reasonably designed to promote compliance with insider trading laws, rules, and regulations,
as well as any applicable listing standards. The text of our insider trading policy is filed as Exhibit 19 to this Report.

 Policies
and Practices Related to the Grant of Certain Equity Awards

 We
have not historically granted any options to purchase our common stock, and we do not have an equity incentive plan in place to facilitate
any such awards. We also do not have any formal policy that requires us to grant, or avoid granting, equity awards to our executive officers
at certain times. The timing of any equity grants to executive officers in connection with new hires, promotions, or other non-routine
grants is tied to the event giving rise to the award (such as an executive officer's commencement of employment or promotion effective
date).

 As
a result, in all cases, the timing of the grant of stock options, if any, would occur independently of the release of any material, non-public
information, and we do not time the disclosure of material non-public information for the purpose of affecting the value or exercise
price of such stock options.

 During
fiscal 2025, no stock options were granted to our executive officers during the period beginning four business days before, and ending
one business day after, the filing or furnishing of such report the filing of a Form 10-Q or Form 10-K, or the filing or furnishing of
a report on Form 8-K that disclosed material nonpublic information.

 ITEM
11. EXECUTIVE COMPENSATION.

 The
following table summarizes all compensation recorded by us in the past two years for:

 our
 principal executive officer or other individual serving in a similar capacity,

 our
 principal financial officer or other individual serving in a similar capacity,

 our
 three most highly compensated executive officers, other than our principal executive officer and our principal financial officer,
 who were serving as executive officers at July 31, 2025 and 2024 as that term is defined under Rule B-7 of the Securities Exchange
 Act of 1934.

 Summary
Compensation Table (in dollars)

 Name
 and Principal

 Fiscal

 Stock

 Non-Equity
 Incentive Plan

 Non-Qualified
 Deferred Compensation

 All
 Other

 Position

 Year

 Salary

 Bonus

 Awards

 Earnings

 Total

 Scott B. Boruff

 2025

 240,000

 -

 -

 -

 -

 10,291

 250,291

 Chief Executive Officer and
 Director (1)

 2024

 -

 -

 -

 -

 -

 102,000

 102,000

 Timothy R. Brady

 2025

 103,750

 -

 179,100

 -

 -

 8,932

 291,782

 Chief Financial Officer (3)

 2024

 -

 -

 -

 -

 -

 -

 -

 Dustin M. Hillis, Pres. &

 2025

 106,249

 -

 100,000

 -

 -

 10,751

 217,000

 Chief Strategy Officer (2)

 2024

 -

 -

 54,500

 -

 -

 12,500

 67,000

 Susan A. Reyes MD

 2025

 24,000

 -

 -

 -

 -

 -

 24,000

 Chief Medical Officer (4)

 2024

 52,000

 -

 6,706

 -

 -

 -

 30,706

 Anand Ijju

 2025

 31,250

 -

 -

 -

 -

 107,738

 138,988

 Chief Technology Officer (5)

 2024

 -

 -

 -

 -

 -

 -

 -

 Theo Davies

 2025

 42,719

 -

 351,575

 -

 -

 66,600

 460,894

 Chief Revenue Officer (6)

 2024

 -

 -

 -

 -

 -

 -

 -

 (1)

 Mr.
 Boruff has served as our Chief Executive Officer and as a Director since March 13, 2018.

 (2)

 Mr.
 Hillis has served as our Chief Strategy Officer since June 15, 2024.

 (3)

 Mr.
 Brady has served as our Chief Financial Officer since December 1, 2024.

 (4)

 Ms.
 Reyes has served as our Chief Medical Officer since September 1, 2020.

 (5)

 Mr.
 Ijju served as our Chief Technology Officer since May 1, 2025.

 (6)

 Mr.
 Davies Served as our Chief Revenue Officer since December 5, 2024

compensation is determined on a case-by-case basis.

 On
September 8, 2022, G. Shayne Bench was appointed to our board of directors for a term of one (1) year. As compensation for Mr. Bench's
service, he received a one (1) year restricted stock award of 846,093 shares of the Company's common stock. The restricted stock
award shall vest ratably, on a monthly basis, at the end of each month of completed service, and any vested shares shall be issued quarterly
in conjunction with the ending of the Company's normal quarterly reporting periods. Mr. Bench's appointment to our Board
of Directors was reaffirmed on September 8, 2023 and September 8, 2024 and on April 24, 2025 and on this date was awarded another 80,000
shares of the Company's common stock. We recognized $17,814 for Mr. Bench in stock-based compensation expense for fiscal year
2025.

 On
August 23, 2024, Micheal J. Burt was appointed to our board of directors for a term of three (3) years and shall continue until canceled
by the Company. Either party has the right to cancel the remaining term of the appointment on each yearly anniversary date by providing
written notice to the other party at least 30 days prior to the anniversary date the cancelation is to become effective. As compensation
for Mr. Burt's service, he received a three (3) year restricted stock award of 2,000,000 shares of the Company's common stock.
The restricted stock award shall vest 1,000,000 shares on August 25, 2024, 333,334 shares on August 25, 2025, 333,333 shares on August
25, 2026 and 333,333 shares on August 25, 2027. We recognized $67,500 for Mr. Burt in stock-based compensation expense for fiscal year
2025.

 On
March 14, 2025, Anthony Chapman was appointed to our board of directors for a term of three (3) years and shall continue until canceled
by the Company with 30 days written notice. As compensation for Mr. Chapman's service, he received a three (3) year restricted
stock award of 400,000 shares of the Company's common stock. The restricted stock award shall vest ratably over a three (3) year
period on the first, second and third anniversary of his appointment to the board of directors.

 On
April 13, 2025, Lawrence H. Kloess, III, a member of FKP Advisors LLC, was appointed to our board of directors for a term of one (1)
year and shall continue until canceled by the Company with 30 days written notice. As compensation for Mr. Kloess's service, he
received a three (3) year restricted stock award of 133,332 shares of the Company's common stock. The restricted stock award shall
vest ratably over a three (3) year period on the first, second and third anniversary of his appointment to the board of directors. We
recognized $5,488 for Mr. Kloess in stock-based compensation expense for fiscal year 2025.

 We
do not currently pay any cash fees to our directors, nor do we pay director's expenses to attend board meetings.

 Executive
Compensation Agreements

 Scott
M. Boruff, CEO

 On
January 31, 2024, we entered into a Non-Employee Chief Executive Officer Engagement Agreement (the "Contract CEO Agreement")
with Platinum Equity Advisors, LLC ("Platinum") to provide the services of Scott M. Boruff as Chief Executive Officer and
Chairman of the Board of Directors of the Company for a term of three (3) years. Effective as of August 1, 2023, the Company shall pay
Platinum an annual base fee of $102,000. The initial base fee is intended to compensate Platinum for a time commitment of up to 1/3 of
the CEO's time, attention, skill and best efforts to the Company. To compensate for a significant increase in its time commitments,
the base fee was increased to $240,000 effective August 1, 2024. Subject to further Board approval, the base fee could be increased to
a maximum annual amount of $306,000 to better reflect the value of any future increases in the CEO's time commitment to the Company.
In addition to the base fee, Platinum is entitled to a discretionary bonus fee, equity awards and other benefits as may be awarded by
our Board of Directors. During the term of the Contract CEO Agreement, Mr. Boruff is entitled to participate in any employee benefit
plans, programs or arrangements of the Company in effect during the engagement period which are generally available to other senior executives
of the Company. On October 1, 2025, Mr. Boruff's annual compensation was increased to $315,000.

 If
the Contract CEO Agreement is terminated by us without cause or by Platinum for good reason, we are obligated to pay Platinum severance
equal to three (3) months base fee and any other earned but unpaid compensation. In addition, if at any time during the term of the Contract
CEO Agreement Platinum is terminated by us without cause within two years after a Change in Control of our company, or in the 90 days
prior the Change in Control at the request of the acquiror, we are obligated to pay Platinum an amount equal to 2.99 times the annual
base fee. "Change in Control" is defined in the Contract CEO Agreement to mean the acquisition by any person of beneficial
ownership of our securities representing greater than 50% of the combined voting power of our then outstanding voting securities.

 Dustin
M. Hillis, President & CSO

 Effective
June 15, 2024, we entered into a Non-Employee Chief Strategy Officer Engagement Agreement (the "Contract CSO Agreement")
with Dustin M. Hillis to provide the services of Chief Strategy Officer for a term of three (3) years. Under the terms of the Contract
CSO Agreement, the Company shall pay Mr. Hillis an annual base fee of $100,000. In addition to the base fee, Mr. Hillis is entitled to
a discretionary bonus fee, equity incentive awards and other benefits as may be awarded by our Board of Directors. Upon collection from
the customer, the Contract CSO Agreement provides for a new business sales commission equal to 15% of the gross amount of any new software
licensing fees and/or support and maintenance fees earned by the Company on sales occurring after the effective date, and shall also
be entitles to an 8% recurring business sales commission on any recurring software support and maintenance fees collected by the Company.
Upon execution of the Contract CSO Agreement, Mr. Hillis received a stock grant of 1,000,000 shares of the Company's common stock.
On January 1, 2025, his agreement was amended, and Mr. Hillis's title was changed to President and Chief Strategy Officer and his
compensation was increased to $150,000 per annum. On October 1, 2025, Mr. Hillis's annual compensation was increased to $225,000.

 If
the Contract CSO Agreement is terminated by us without cause, or by Mr. Hillis for good reason, we are obligated to pay Mr. Hillis a
severance equal to one (1) month base fee, any earned and unpaid new sales business commissions, and any recurring business sales commissions
with respect to customers of the Company as of the termination date and applicable to all products and services sold or provided to such
customers on or before the one year anniversary of the termination date. If Mr. Hillis terminates the Contract CSO Agreement without
good reason, he shall receive any unpaid portion of the base fee earned through the termination date and any new business sales commissions
earned through the termination date. If the Company terminates the Contract CSO Agreement for cause, Mr. Hillis shall receive any unpaid
portion or the base fee earned through the termination date.

 Timothy
R. Brady, CFO

 Effective
as of October 1, 2024, Timothy R. Brady was appointed by the Board of Directors (the "Board") of SafeSpace Global Corporation to the position of Chief Financial Officer. Mr. Brady initially served as our Chief Financial Officer
on a fractional basis and commenced service as Chief Financial Officer on a full-time basis as of December 1, 2024. In connection with
the commencement of his full-time service to the Company in December, the Company entered into a Non-Employee Chief Financial Officer
Engagement Agreement dated December 1, 2024. Pursuant to the agreement, Mr. Brady is entitled to an initial monthly base salary of $10,000
and received 2,000,000 shares of the Company's common stock. The Board or its compensation committee may grant Mr. Brady other
long-term incentive awards in the form of equity awards, cash incentives or otherwise, from time to time and in the discretion of the
Board or its committee. Mr. Brady is also entitled to a 2% override on any and all Company sales, including initial sales and subsequent
recurring sales. No overrides will be considered earned by the Company until the amount is collected from the customer. The Company has
agreed to pay Mr. Brady an annual bonus subject to achievement by the Company of Board-established corporate goals and to recognized
other achievements by the Company or Mr. Brady during the year. Mr. Brady is entitled to participate in any employee benefit plans, programs
and arrangements of the Company in effect during the engagement period which are generally available to other senior executives of the
Company (including, without limitation, group medical insurance plans, life insurance plans, and 401(k) plans), subject to and on a consistent
basis with the terms, conditions and overall administration of such plans, programs and arrangements. A First Amendment was signed effective
April 1, 2025, and the monthly base salary was increased to $12,500. At the discretion of the Board of Directors, Executive's Base
Fee may be increased. On October 1, 2025, Mr. Brady's annual compensation was increased to $225,000.

 The
Employment Agreement terminates upon the death or disability of Mr. Brady, and may be terminated by us for cause, or by Mr. Brady for
any reason. If the Employment Agreement is terminated by us for cause, upon his death or disability, at non-renewal or by Mr. Brady,
he is only entitled to receive base salary accrued but not paid through the date of termination, and in the case of termination due to
death or disability, a pro rata payment of the annual incentive earned for the year of termination. If the Employment Agreement is terminated
by us without cause or by Mr. Brady for good reason, we are obligated to pay him severance equal to one year's base salary and
any unpaid incentive compensation. In addition, if at any time during the term of the Employment Agreement Mr. Brady's employment
is terminated by us without cause within two years after a Change in Control of our company, or in the 90 days prior the Change in Control
at the request of the acquiror, we are obligated to pay him an amount equal to 2.99 times his annualized compensation. "Change
in Control" is defined in the Employment Agreement to mean the acquisition by any person of beneficial ownership of our securities
representing greater than 50% of the combined voting power of our then outstanding voting securities. The Employment Agreement contains
customary invention assignment, non-compete and non-solicitation provisions.

 Anand
Ijju, CTO

 On
April 10, 2025, we appointed Mr. Anand Ijju, as our Chief Technology Officer (CTO). Mr. Ijju's employment with the Company begin
on May 1, 2025. Mr. Ijju entered into a three-year agreement with the Company. As compensation, the Company agreed to pay Mr. Ijju an
annual salary of $150,000 and Mr. Ijju is entitled to discretionary bonuses as may be awarded from time to time by the Company's
Board of Directors. As additional compensation the Company granted Mr. Ijju a stock grant of 500,000 shares of the Company's common
stock. The stock grant shall be non-qualified and shall become vested annually over three years beginning on May 1, 2026. Mr. Ijju is
entitled to participate in any employee benefit plans, programs and arrangements of the Company in effect during the engagement period
which are generally available to other senior executives of the Company (including, without limitation, group medical insurance plans,
life insurance plans, and 401(k) plans), subject to and on a consistent basis with the terms, conditions and overall administration of
such plans, programs and arrangements.

 The
Employment Agreement terminates upon the death or disability of Mr. Ijju, and may be terminated by us for cause, or by Mr. Ijju for any
reason. If the Employment Agreement is terminated by us for cause, upon his death or disability, at non-renewal or by Mr. Ijju, he is
only entitled to receive base salary accrued but not paid through the date of termination, and in the case of termination due to death
or disability, a pro rata payment of the annual incentive earned for the year of termination. If the Employment Agreement is terminated
by us without cause or by Mr. Ijju for good reason, we are obligated to pay him severance equal to one year's base salary and any
unpaid incentive compensation. In addition, if at any time during the term of the Employment Agreement Mr. Ijju's employment is
terminated by us without cause within two years after a Change in Control of our company, or in the 90 days prior the Change in Control
at the request of the acquiror, we are obligated to pay him an amount equal to 2.99 times his annualized compensation. "Change
in Control" is defined in the Employment Agreement to mean the acquisition by any person of beneficial ownership of our securities
representing greater than 50% of the combined voting power of our then outstanding voting securities. The Employment Agreement contains
customary invention assignment, non-compete and non-solicitation provisions.

 Susan
A. Reyes, M.D., CMO

 On
January 31, 2024, in connection with the appointment of Susan A. Reyes, MD as Chief Medical Officer of the Company, the Company and Dr.
Reyes entered into an employment agreement (the "Reyes Employment Agreement") with an initial term of three (3) years. Effective
as of August 1, 2024, the Company shall pay Dr. Reyes a base salary at the rate of $24,000 per annum. The initial base salary is intended
to compensate Dr. Reyes for a fractional devotion of her time, attention, skill and best efforts to the Company. At the discretion of
the Chief Executive Officer, the base salary may be increased to a maximum annual amount of $92,000 to better reflect the value of any
future increases in Dr. Reyes' time commitment to the Company. Dr. Reyes is also entitled to paid vacation and sick leave, and
participation in any employee benefit plans or programs we may offer. In addition, Dr. Reyes is eligible for equity awards and other
benefits as approved by the Board of Directors. The initial term of the Employment Agreement will automatically be renewed for an additional
one-year term unless either party provides notice of non-renewal.

 The
Employment Agreement terminates upon the death or disability of Dr. Reyes, and may be terminated by us for cause, or by Dr. Reyes for
any reason. If the Employment Agreement is terminated by us for cause, upon her death or disability, at non-renewal or by Dr. Reyes,
she is only entitled to receive base salary accrued but not paid through the date of termination, and in the case of termination due
to death or disability, a pro rata payment of the annual incentive earned for the year of termination. If the Employment Agreement is
terminated by us without cause or by Dr. Reyes for good reason, we are obligated to pay her severance equal to one year's base
salary and any unpaid incentive compensation. In addition, if at any time during the term of the Employment Agreement Dr. Reyes'
employment is terminated by us without cause within two years after a Change in Control of our company, or in the 90 days prior the Change
in Control at the request of the acquiror, we are obligated to pay her an amount equal to 2.99 times her annualized compensation. "Change
in Control" is defined in the Employment Agreement to mean the acquisition by any person of beneficial ownership of our securities
representing greater than 50% of the combined voting power of our then outstanding voting securities. The Employment Agreement contains
customary invention assignment, non-compete and non-solicitation provisions.

 Theo
Davies, CRO

 On
April 17, 2025, we appointed Mr. Theo Davies, as our Chief Revenue Officer (CRO), effective immediately. Mr. Davies was previously our
Chief Commercial Officer. As compensation, the Company agreed to pay Mr. Davies an annual salary of $150,000 and Mr. Davies is entitled
to discretionary bonuses as may be awarded from time to time by the Company's Board of Directors. As additional compensation the
Company granted Mr. Davies a stock grant of 500,000 shares of the Company's common stock, which vested immediately. Mr. Davies
will also receive an annual health insurance benefit allowance of $1,800. In addition, Mr. Davies shall be paid a 2.0% commission on
the gross amount of any and all Company domestic revenue and 5.0% commission on the gross amount of any and all Company international
revenue, the 5% commission will be reduced to 2%, when Mr. Davies finds his replacement.

 The
Employment Agreement terminates upon the death or disability of Mr. Davies, and may be terminated by us for cause, or by Mr. Davies for
any reason. If the Employment Agreement is terminated by us for cause, upon his death or disability, at non-renewal or by Mr. Davies,
she is only entitled to receive base salary accrued but not paid through the date of termination, and in the case of termination due
to death or disability, a pro rata payment of the annual incentive earned for the year of termination. If the Employment Agreement is
terminated by us without cause or by Mr. Davies for good reason, we are obligated to pay his severance equal to one year's base
salary and any unpaid incentive compensation. In addition, if at any time during the term of the Employment Agreement Mr. Davies'
employment is terminated by us without cause within two years after a Change in Control of our company, or in the 90 days prior the Change
in Control at the request of the acquiror, we are obligated to pay her an amount equal to 2.99 times her annualized compensation. "Change
in Control" is defined in the Employment Agreement to mean the acquisition by any person of beneficial ownership of our securities
representing greater than 50% of the combined voting power of our then outstanding voting securities. The Employment Agreement contains
customary invention assignment, non-compete and non-solicitation provisions.

 ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 The
following table sets forth, as of October 27, 2025, the ownership of our common stock by each stockholder who is known to us to beneficially
own more than 5% of our outstanding common stock, by each director and nominee for the office of director, by our named executive officers,
and by all directors and executive officers as a group. On that date, there were 187,511,196 shares of our common stock issued and outstanding.

 Name
 and Address of Beneficial Owner

 Amount
 and Nature of Beneficial Ownership

 Percent
 of Shares

 Directors and Named Executive
 Officers

 Scott M. Boruff

 22,767,697
 (1)

 12.2
 %

 Timothy R. Brady

 2,000,000

 1.1
 %

 Dustin M. Hillis

 7,254,500
 (2)

 3.9
 %

 G. Shayne Bench

 2,426,093
 (3)

 1.3
 %

 Micheal J. Burt

 1,909,090

 1.0
 %

 Theo Davies

 2,500,000

 1.3
 %

 Anand Ijju

 1,000,000

 *

 Susan A. Reyes

 1,775,026

 *

 Anthony Chapman

 1,500,000

 *

 Lawrence
 H. Kloess, III

 1,000,000

 *

 All directors and current
 executive officers as a group

 44,132,406

 23.6
 %

 *
 Less
 than 1.0%.

 ( 1)
 Consists
 entirely of shares held by Platinum Equity Advisors, LLC, of which Mr. Boruff's spouse,
 Julie Boruff, is the sole member.

 ( 2)
 Includes
 6,020,000 shares held by All Things New Ventures, LLC, of which Mr. Hillis is the sole member.

 ( 3)
 Includes
 2,346,093 shares held by Bucuti Investments, LLC, of which Mr. Bench is the sole member.

 ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 Other
than compensation arrangements, the following is a description of transactions to which we were a participant or will be a participant
to, in which:

 the
 amounts involved exceeded or will exceed the lesser of 1% of our total assets or $120,000; and

 any
 of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of the
 foregoing persons, had or will have a direct or indirect material interest.

 The
Company has periodically obtained loans from related parties, primarily shareholders for which there are no formal written
commitment for continued support by shareholders or others. Amounts loaned primarily relate to amounts paid to vendors. The loans
are considered temporary in nature and have not been formalized by any written agreement. As of July 31, 2025 and 2024, related
parties were owed $2,339 and $30,925, respectively, which are included in Accounts payable and accrued expenses, related party on
the consolidated balance sheets (See Note 4 - Accounts Payable and Accrued Expenses, Related Party). The amounts owed
are payable on demand and carry no interest. The amounts and terms of the related party loans may not necessarily be indicative of
the amounts and terms that would have been incurred had comparable transactions been entered into with independent third
parties.

 For
compensation after August 1, 2023, we entered into a Non-Employee Chief Executive Officer Engagement Agreement (the "Contract
CEO Agreement") with Platinum Equity Advisors, LLC ("Platinum Equity"), a related party, to provide the services
of our CEO and Chairman of the Board of Directors. Platinum Equity Advisors, LLC is a related party, is our largest shareholder, and
is owned 100% by the spouse of our CEO and Charman of our Board of Directors. At July 31, 2025 and 2024, we owed Platinum Equity
$5,492 and $151,386, respectively, for amounts related to the Contract CEO Agreement. The amount owed is included in Accounts
payable and accrued expenses, related party on the interim consolidated balance sheets (See Note 4 - Accounts Payable and Accrued
Expenses, Related Party). The foregoing description of the Contract CEO Agreement does not purport to be complete and is
qualified by the text of the Contract CEO Agreement, which is filed as Exhibit 10.2 to this Report.

 On
December 31, 2024, we issued a Promissory Note to Platinum Equity Advisors, LLC in the principal amount of $373,957 which included $51,283
of unamortized deferred financing costs (See Note 6 – Notes Payable, Related Party). At July 31, 2025 all outstanding balances
were paid off. The note, plus accrued interest, is due on December 12, 2024. At July 31, 2024, accrued but unpaid interest on the note
was $5,583 (See Note 4 – Accounts Payable and Accrued Expenses, Related Party). The amount and terms of the related
party loan may not necessarily be indicative of the amount and terms that would have been incurred had comparable transactions been entered
into with independent third parties. On June 12, 2024, the company issued a Promissory Note to Platinum Equity Advisors, LLC in the principal
amount of $410,207 (See Note 6 – Notes Payable, Related Party). The note, plus accrued interest, was due on December 12, 2024. At
July 31, 2024, accrued but unpaid interest on the note was $5,583.

 For
the fiscal year ending July 31, 2025, the Company recognized $57,006 in office rent expense included in "Selling, general and administrative"
on our consolidated statements of operations related to a month-to-month sublease agreement with Blue Earth Resources, Inc. ("BERI"),
an entity related to the Company through common management control for use of certain office space.

Independence

 We
currently have three independent directors. Because our common stock is not currently listed on a national securities exchange, we have
used the definition of "independence" of The Nasdaq Stock Market to make this determination. Nasdaq Listing Rule 5605(a)(2)
provides that an "independent director" is a person other than an executive officer or employee of the company or any other
individual having a relationship that, in the opinion of the company's board of directors, would interfere with the exercise of
independent judgment in fulfilling the responsibilities of a director. The Nasdaq listing rules provide that a director cannot be considered
independent if:

 the
 director is, or at any time during the past three years was, an employee of the Company;

 the
 director or a family member of the director accepted any compensation from the Company in excess of $120,000 during any period of
 12 consecutive months within the three years preceding the independence determination (subject to certain exclusions, including,
 among other things, compensation for board or board committee service);

 a
 family member of the director is, or at any time during the past three years was, an executive officer of the Company;

 the
 director or a family member of the director is a partner in, controlling stockholder of, or an executive officer of an entity to
 which the Company made, or from which the Company received, payments for property or services in the current or any of the past three
 fiscal years that exceed 5% of the recipient's consolidated gross revenue for that year or $200,000, whichever is greater (subject
 to certain exclusions);

 the
 director or a family member of the director is employed as an executive officer of an entity where, at any time during the past three
 years, any of the executive officers of the Company served on the compensation committee of such other entity; or

 The
 director or a family member of the director is a current partner of the Company's outside auditor, or at any time during the
 past three years was a partner or employee of the Company's outside auditor, and who worked on the Company's audit.

 The
Company does not currently have a separately designated audit, nominating, or compensation committee.

 ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 The
following table sets forth the aggregate fees billed for each of the last two fiscal years for professional services rendered by the
principal accountant for the audit of the Company's annual financial statements and review of financial statements included in
the Company's quarterly reports or services that are normally provided by the accountant in connection with statutory and regulatory
filings or engagements for those fiscal years.

 July

 July

 Audit Fees

 $
 57,500

 $
 42,500

 All Other Fees

 -

 -

 Total

 $
 57,500

 $
 42,500

 Audit
Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors

 Our
Audit Committee pre-approves all audit and permissible non-audit services. These services may include audit services, audit-related services,
tax services, and other services. Our Audit Committee approves these services on a case-by-case basis.

 PART
IV

 ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 Exhibit
 No.

 Description

 3.1

 Articles
 of Incorporation (incorporated by reference to Exhibit 3.1 to current report on Form 8-K filed with the Securities and Exchange Commission
 on May 9, 2025)

 3.2

 Amended
 and Restated Bylaws (incorporated by reference to Exhibit 3.2 to current report on Form 8-K filed with the Securities and Exchange
 Commission on May 9, 2025)

 4.1*

 Description of Securities

 10.1

 Employment
 Agreement with Susan A. Reyes, M.D., dated January 31, 2024 (incorporated by reference to Exhibit 10.4 to quarterly report on Form
 10-Q for the quarter ended January 31, 2024)

 10.2

 Non-Employee
 Chief Executive Officer Engagement Agreement with Platinum Equity Advisors, LLC, dated January 31, 2024 (incorporated by reference
 to Exhibit 10.1 to quarterly report on Form 10-Q for the quarter ended January 31, 2024)

 10.3

 Non-Employee
 President & Chief Strategy Officer Engagement Agreement between the Company and Dustin M. Hillis, dated January 1, 2025 (incorporated
 by reference to Exhibit 10.2 to current report on Form 8-K filed with the SEC on February 24, 2025)

 10.4

 First
 Amendment to Non-Employee President & Chief Strategy Officer Engagement Agreement with Dustin M. Hillis, dated January 1, 2025(incorporated
 by reference to Exhibit 10.2 to quarterly report on Form 10-Q for the quarter ended April 30, 2025)

 10.5

 Consulting
 Agreement between the Company and G. Shayne Bench, effective August 26, 2022 (incorporated by reference to Exhibit 10.6 to annual
 report on Form 10-K for the fiscal year ended July 31, 2022)

 10.6

 Statement Of Work between the Company and Timothy R. Brady dated September 19, 2024 and beginning October 1, 2024 (incorporated by reference to Exhibit 10.8 to annual report on Form 10-K for the fiscal year ended July 31, 2024)

 10.7

 Non-Employee
 Chief Financial Officer Engagement Agreement with Timothy R. Brady, dated December 1, 2024 (incorporated by reference to Exhibit
 10.1 to current report on Form 8-K filed on February 24, 2025)

 10.8

 First
 Amendment to Non-Employee Chief Financial Officer Engagement Agreement with Timothy R. Brady, dated April 1, 2025 (incorporated by
 reference to Exhibit 10.1 to quarterly report on Form 10-Q for the quarter ended April 30, 2025)

 10.9

 Chief
 Technology Officer Employment Agreement with Anand Ijju, dated May 1, 2025 (incorporated by reference to Exhibit 10.1 to current
 report on Form 8-K filed with the SEC on April 10, 2025)

 10.10

 Chief
 Revenue Officer Employment Agreement with Theo Davies, dated April 17, 2025 (incorporated by reference to Exhibit 10.1 to current
 report on Form 8-K filed with the SEC on April 17, 2025)

 10.11

 Board
 Member Agreement with FKP Advisors LLC, dated April 15, 2025 (incorporated by reference to Exhibit 10.1 to current report on Form
 8-K filed with the SEC on April 21, 2025)

 19*

 Insider Trading Policy

 24*

 Powers of Attorney

 31*

 Chief Executive Officer and Chief Financial Officer Certification pursuant to section 302 of the Sarbanes-Oxley Act of 2002

 32*

 Chief Executive Officer and Chief Financial Officer Certification pursuant to section 906 of the Sarbanes-Oxley Act of 2002

 101*

 statements from the annual report on Form 10-K for the year ended July 31, 2025, as filed with the Securities and Exchange Commission,
 of Shareholders' Equity, (iv) Statements of Cash Flows, (v) Notes to Financial Statements, (vi) the information set forth in
 Part II, Item 9B, and (vii) the information set forth in Part III, Item 10.

 104*

 Cover

 *
Filed Herewith

 Executive Compensation Agreement

 ITEM
16. FORM 10-K SUMMARY.

 None.

 SIGNATURES

 Pursuant
to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

 Date:

 By:

 /s/
 Scott M. Boruff

 Scott
 M. Boruff

 President,
 Chief Executive Officer

 Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.

 Signature

 Title

 Date

 /s/ Scott
 M. Boruff

 Chief Executive
 Officer, Director

 Scott M. Boruff

 (principal executive officer)

 /s/ Timothy
 R. Brady

 Chief Financial
 Officer

 Timothy R. Brady

 (principal financial and accounting officer)

 *

 G. Shayne Bench

 *

 Micheal J. Burt

 *

 Anthony Chapman

 *

 Lawrence H. Kloess III

 *Scott
M. Boruff, by signing his name hereto, does hereby sign this document on behalf of each of the above-named directors of the registrant
pursuant to Powers of Attorney duly executed by such persons.

 Date:

 By:

 /s/
 Scott M. Boruff

 Scott
 M. Boruff

 Attorney
 in Fact

TO FINANCIAL STATEMENTS

 Page

 Fiscal
 Years Ended July 31, 2025 and 2024

 Report of Independent Registered Public Accounting Firm (PCAOB ID: 910)

 Consolidated
 Balance Sheets

 Consolidated
 Statements of Operations

 Consolidated
 Statements of Changes in Stockholders' Deficit

 Consolidated
 Statements of Cash Flows

 Notes
 to Consolidated Financial Statements

 - F-24

 F- 1

 REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 To
the Board of Directors and

 Stockholders
of SafeSpace Global Corporation, Inc. 311 S. Weisgarber Road

 Knoxville,
TN 37919

 Opinion
on the Financial Statements

 We
have audited the accompanying consolidated balance sheets of SafeSpace Global Corporation, Inc. (the "Company") as of July
31, 2025 and 2024, and the related consolidated statements of operations, changes in stockholders' deficit, and cash flows for
each of the years in the two-year period ended July 31, 2025, and the related notes (collectively referred to as the financial statements).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of July 31,
2025 and 2024, and the results of its operations and its cash flows for each of the years in the two- year period ended July 31, 2025,
in conformity with accounting principles generally accepted in the United States of America.

 Basis
for Opinion

 These
consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion
on the Company's consolidated financial statements based on our audits. We are a public accounting firm registered with the Public
Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud.
The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part
of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing
an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that our audits provide a reasonable basis for our opinion.

 Critical
Audit Matters

 Critical
audit matters are matters arising from the current period audit of the consolidated financial statements that were communicated or required
to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the consolidated financial
statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there were no critical audit
matters.

 /s/ Rodefer
Moss & Co, PLLC

 We
have served as the Company's auditor since 2019.

 Knoxville,
Tennessee

 October
29, 2025

 F- 2

 CONSOLIDATED
BALANCE SHEETS

 July

 July

 ASSETS

 CURRENT ASSETS:

 Cash and cash
 equivalents

 $
 7,546,390

 $
 175,562

 Accounts receivable, net

 -

 14,000

 Prepaid
 expenses

 94,044

 33,022

 Total current assets

 7,640,434

 222,584

 OTHER ASSETS:

 Intangibles

 290,469

 506,743

 Total assets

 $
 7,930,903

 $
 729,327

 LIABILITIES AND STOCKHOLDERS'
 DEFICIT

 CURRENT LIABILITIES:

 expenses

 $
 315,707

 $
 182,784

 expenses, related party

 7,831

 187,894

 expenses

 7,831

 187,894

 Payroll related liabilities

 42,473

 16,637

 Notes payable, related
 party

 -

 410,207

 Notes
 payable

 -

 225,000

 Total current and total
 liabilities

 366,011

 1,022,522

 STOCKHOLDERS' DEFICIT:

 Common stock par value
 $ 0.001; 200,000,000 shares authorized; 185,497,862 and 79,853,696 shares issued and outstanding as of July 31, 2025 and 2024, respectively

 185,498

 79,854

 Additional paid-in capital

 28,332,617

 15,941,603

 Accumulated
 deficit

 ( 20,953,223
)

 ( 16,314,652
)

 Total stockholders'
 equity (deficit)

 7,564,892

 ( 293,195
)

 Total liabilities and
 stockholders' deficit

 $
 7,930,903

 $
 729,327

 See
accompanying notes to the consolidated financial statements.

 F- 3

 CONSOLIDATED
STATEMENTS OF OPERATIONS

 2025

 2024

 For
 the Years Ended July 31,

 2025

 2024

 REVENUE:

 Contract revenue

 $
 -

 $
 322,000

 Cost of contracts

 -

 ( 239,948
)

 Gross profit

 -

 82,052

 OPERATING EXPENSES:

 Selling, general &
 administrative

 2,756,225

 516,280

 Stock-based compensation

 1,575,211

 186,643

 Amortization of intangibles

 421,955

 221,919

 Impairment of intangibles

 46,225

 140,770

 Total operating expenses

 4,799,616

 1,065,612

 OPERATING
 LOSS

 ( 4,799,616
)

 ( 983,560
)

 OTHER INCOME (EXPENSE):

 Interest income

 85,909

 -

 Interest expense

 ( 38,509
)

 ( 55,079
)

 Extinguishment of liabilities

 113,645

 279,903

 Gain
 on settlements

 -

 56,250

 Total other income (expense)

 161,045

 281,074
)

 NET
 LOSS

 $
 ( 4,638,571
)

 $
 ( 702,486
)

 NET LOSS PER COMMON SHARE

 Basic
 and diluted

 $
 ( 0.04
)

 $
 ( 0.01
)

 WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 Basic and diluted

 130,930,264

 70,048,860

 See
accompanying notes to the consolidated financial statements.

 F- 4

 STATEMENTS
OF CHANGES IN STOCKHOLDERS' DEFICIT

 FOR
THE YEARS ENDED JULY 31, 2025 AND 2024

 Additional

 Total

 Common
 Stock

 Paid-In

 Accumulated

 Stockholders'

 Shares

 Amount

 Capital

 Deficit

 Deficit

 Balances at July 31, 2023

 68,016,167

 68,016

 14,878,282

 ( 15,612,166
)

 ( 665,868
)

 Net loss

 ( 702,486
)

 ( 702,486
)

 Shares issued for cash

 5,500,000

 5,500

 544,500

 -

 550,000

 Shares issued for payment
 of accrued expenses

 3,385,154

 3,385

 335,131

 -

 338,516

 Shares issued for services

 1,100,000

 1,100

 ( 1,100
)

 -

 -

 Shares issued for loan
 modification

 570,344

 ( 571
)

 -

 -

 compensation

 1,282,031

 1,282

 185,361

 -

 186,643

 Balances at July 31, 2024

 79,853,696

 79,854

 15,941,603

 ( 16,314,652
)

 ( 293,195
)

 Balances

 79,853,696

 79,854

 15,941,603

 ( 16,314,652
)

 ( 293,195
)

 Net loss

 ( 4,638,571
)

 ( 4,638,571
)

 Shares issued for cash

 92,626,548

 92,626

 10,672,074

 -

 10,764,700

 Shares issued for settlement

 1,572,034

 1,572

 26,552

 -

 28,124

 Shares issued for services

 1,160,000

 1,160

 111,340

 -

 112,500

 Issuance of shares for
 the conversion of debt and related accrued interest

 493,463

 94,728

 -

 95,221

 compensation

 9,792,121

 9,793

 1,486,320

 -

 1,496,113

 Balances at July 31,
 2025

 185,497,862

 $
 185,498

 $
 28,332,617

 $
 ( 20,953,223
)

 $
 7,564,892

 Balances

 185,497,862

 $
 185,498

 $
 28,332,617

 $
 ( 20,953,223
)

 $
 7,564,892

 See
accompanying notes to the consolidated financial statements.

 F- 5

 CONSOLIDATED
STATEMENTS OF CASH FLOWS

 2025

 2024

 For
 the Years Ended July 31,

 2025

 2024

 CASH FLOWS FROM OPERATING
 ACTIVITIES

 Net loss

 $
 ( 4,638,571
)

 $
 ( 702,486
)

 Adjustments to reconcile
 loss to net cash used in operating activities:

 421,955

 221,919

 Stock-based compensation

 1,575,211

 186,643

 Impairment of intangibles

 46,225

 140,770

 Extinguishment of liabilities

 ( 113,645
)

 ( 279,903
)

 Gain on settlements

 -

 ( 56,250
)

 Shares issued for services

 112,500

 -

 Amortization of debt discount

 -

 -

 Changes in operating assets and liabilities:

 Accounts receivable, net

 14,000

 ( 14,000
)

 Prepaid expenses and other
 current assets

 ( 61,021
)

 1,070

 expenses

 193,569

 19,455

 expenses, related party

 ( 226,532
)

 ( 34,957
)

 Payroll
 related liabilities

 -

 250,010

 NET
 CASH USED BY OPERATING ACTIVITIES

 ( 2,676,309
)

 ( 267,729
)

 CASH FLOWS FROM INVESTING
 ACTIVITIES

 Cash paid for development
 of intangible assets

 ( 175,747
)

 -

 NET
 CASH USED BY INVESTING ACTIVITIES

 ( 175,747
)

 -

 CASH FLOWS FROM FINANCING
 ACTIVITIES

 Proceeds from sale of common
 stock

 10,764,700

 550,000

 (Payments) proceeds from
 related party loans

 ( 17,570
)

 114,989

 Payments of amounts owed
 to related parties

 ( 474,246
)

 ( 222,109
)

 Principal
 payments on short-term debt

 ( 50,000
)

 NET
 CASH PROVIDED BY FINANCING ACTIVITIES

 10,222,884

 442,880

 Net change in cash and cash equivalents

 7,370,828

 175,151

 Cash
 and cash equivalents, beginning of period

 175,562

 Cash
 and cash equivalents, end of period

 $
 7,546,390

 $
 175,562

 SUPPLEMENTAL CASH FLOW INFORMATION

 Cash paid for interest

 $
 -

 $
 -

 SIGNIFICANT NON-CASH INVESTING
 AND FINACING ACTIVITIES

 Capital expenditures included
 in accrued expenses

 $
 76,848

 $
 -

 Shares issued for payment
 of payroll related liabilities

 $
 -

 $
 338,516

 Issuance of common stock
 for payment of accrued expenses

 $
 28,124

 $
 -

 Shares issued for extinguishment
 of convertible debt

 $
 175,000

 $
 -

 See
accompanying notes to the consolidated financial statements.

 F- 6

 NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS

 July
31, 2025 and 2024

 NOTE
1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Global Corporation (collectively the "Company," "we," "our" or "us") is a multimodal
AI technology solutions company with a dedicated team focused on driving safety innovation across multiple industries. We are currently
marketing products and solutions that utilize advanced AI monitoring tools to enhance resident safety, reduce the risk of injuries, and
improve overall care efficiency.

 Basis
of Presentation

 The
accompanying consolidated financial statements include those of SafeSpace Global Corporation and its subsidiaries, after elimination
of all intercompany accounts and transactions. We have prepared the accompanying consolidated financial statements in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP") and pursuant to the rules and regulations
of the United States Securities and Exchange Commission (the "SEC").

 Consolidation
Policy

 Our
consolidated financial statements are consolidated in accordance with U.S. GAAP and include our accounts and the accounts of our wholly
owned subsidiaries. We eliminate all intercompany transactions from our financial results.

 Business
Combinations

 We
account for business combinations under the acquisition method of accounting. The acquisition method requires that the acquired assets
and liabilities, including contingencies, be recorded at fair value determined on the acquisition date and that changes thereafter be
reflected in income (loss). The estimation of fair values of the assets and liabilities assumed involves several estimates and assumptions
that could differ materially from the actual amounts recorded. The results of the acquired businesses are included in our results from
operations beginning from the day of acquisition.

 Allowance
for Credit losses

 In
accordance with ASC 326, Financial Instruments – Credit Losses, we recognize an allowance for credit losses on acquired financial
assets with credit deterioration since origination. The allowance of credit losses is measured based on the Current Expected Credit Loss
(CECL) model, which requires an estimate of the expected credit losses over the life of the financial asset. This estimate considers
historical loss information, current conditions, and reasonable and supportable forecasts. The allowance for credit losses, if any, is
recorded as a reduction to the carrying amount of the financial asset, with a corresponding charge to earnings.

 Risk
and Uncertainties

 Factors
that could affect our future operating results and cause actual results to vary materially from management's expectation include,
but are not limited to: our ability to maintain and secure adequate capital to fund our operations and fully develop our product(s);
our ability to source strong opportunities with sufficient risk adjusted returns; acceptance of the terms and conditions of our licenses
and/or the acceptance of our royalties and fees; the nature and extent of competition from other companies that may reduce market share
and create pressure on pricing and investment return expectations; changes in the projects in which we plan to invest which result from
factors beyond our control, including, but not limited to, a change in circumstances, capacity and economic impacts; changes in laws,
regulations, accounting, taxation, and other requirements affecting our operations and business. Negative developments in these or other
risk factors could have a significant adverse effect on our financial position, results of operations and cash flows.

 F- 7

 Use
of Estimates

 The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those
estimates. We base our estimates on experience and various other assumptions that are believed to be reasonable under the circumstances.
We evaluate our estimates and assumptions on a regular basis and actual results may differ from those estimates.

 Reclassifications

 Certain
prior period amounts may be reclassified to conform to current period presentation with no changes to previously reported net loss or
stockholders' deficit.

 Cash
and Cash Equivalents

 We
consider all highly liquid short-term investments with a maturity of three months or less at the time of purchase to be cash equivalents.
The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution.
The balance at times may exceed federally insured limits. No loss has been experienced and management does not believe we are exposed
to any significant credit risk.

 Accounts
Receivable

 Accounts
receivable are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers
based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company
does not require collateral.

 Management
periodically assesses the Company's accounts receivable and, if necessary, establishes an allowance for estimated uncollectible
amounts. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical
collection information and existing economic conditions. Accounts determined to be uncollectible are charged to operations when that
determination is made.

 We
had no accounts receivable at July 31, 2025. At July 31, 2024, accounts receivable was $ 14,000 and did not include any reserve for uncollectible
accounts. We recorded no bad debt expense, write-offs, or recoveries for the years ended July 31, 2025 and 2024.

 Concentration
of Credit Risk

instruments that potentially expose the Company to credit risk consist of demand deposits with a financial institution. The Company is
exposed to credit risk on its cash and cash equivalents in the event of default by the financial institution to the extent account balances
exceed the amount insured by the FDIC, which is $ 250,000.

 Fair
Value of Financial Instruments

 Fair
value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between
market participants. A fair value hierarchy has been established for valuation inputs that gives the highest priority to quoted prices
in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as
follows:

 Level
1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity can access
at the measurement date.

 F- 8

 Level
2 Inputs – Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly
or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or
similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability
(such as interest rates, volatilities, prepayment speeds, credit risks, etc.) or inputs that are derived principally from or corroborated
by market data by correlation or other means.

 Level
3 Inputs – Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity's own assumptions
about the assumptions that market participants would use in pricing the assets or liabilities.

instruments consist of cash and cash equivalents, accounts receivable, accounts payable and borrowings. The fair value of current financial
assets and current financial liabilities approximates their carrying value because of the short-term maturity of these financial instruments.

 Property
and Equipment

 Property
and equipment are stated at cost, net of accumulated depreciation. Expenditures for major additions and improvements are capitalized
while minor replacements and maintenance and repairs, which do not improve or extend the life of such assets, are charged to operations
as incurred. Disposals are removed at cost less accumulated depreciation, and any resulting gain or loss is reflected in the consolidated
statements of operations. Depreciation is calculated using the straight-line method which depreciates the assets over the estimated useful
lives of the depreciable assets ranging from 5 five to seven years.

 Intangible
Assets

 Intangible
assets consist of patents, our website and the costs of software developed for internal use. Certain payroll and stock-based
compensation costs incurred are allocated to the intangible assets. We determine the amount of costs to be capitalized based on the
time spent by employees or outside contractors on the projects. Intangible assets are amortized on a straight-line basis over their
expected useful lives, which approximate 20 -years
for patents, 3 -years
for internally developed software and 2 -years
for website related cost. Intangible assets that are subject to amortization are evaluated for impairment at least annually, and
additionally whenever events or changes in circumstances indicate that it is more likely than not that an asset may be impaired. The
impairment test for indefinite-lived intangible assets consists of a comparison of the fair value of the intangible asset with its
carrying amount. An impairment loss would be recognized for the amount by which the carrying value exceeds the fair value of the
asset. The Company has recognized intangible asset impairment charges of $ 46,225
and $ 140,770,
respectively during the years ended July 31, 2025 and 2024. See Note 2 - Intangibles, Net.

 Intangibles,
net was $ 290,469 and $ 506,743 for the years ended July 31, 2025 and 2024, respectively.

 Derivative
Liability

 Options,
warrants, convertible notes, or other contracts, if any, are evaluated to determine if those contracts, or embedded components of those
contracts, qualify as derivatives to be separately accounted for in accordance with Financial Accounting Standards Board ("FASB")
Accounting Standards Codification ("ASC") Topic 815, "Derivatives and Hedging," (paragraph 815-10-05-4
and Section 815-40-25). The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market
each balance sheet date and recorded as either an asset or a liability. The change in fair value is recorded in the consolidated statements
of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked
to fair value at the date of conversion, exercise, or cancellation and then the related fair value is reclassified to equity.

 In
circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated, and there are also other
embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments
are accounted for as a single, compound derivative instrument.

 F- 9

 The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed
at the end of each reporting period. Equity instruments that are initially classified as equity that become subject to reclassification
are reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will
be classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument is expected
within 12 months of the balance sheet date.

 The
Company adopted Section 815-40-15 of the FASB ASC ("Section 815-40-15") to determine whether an instrument (or an
embedded feature) is indexed to the Company's own stock. Section 815-40-15 provides that an entity should use a two-step approach
to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the
instrument's contingent exercise and settlement provisions.

 We
utilize a binomial option pricing model to compute the fair value of the derivative liability and to mark to market the fair value of
the derivative liability at each balance sheet date. We record the change in the fair value of the derivative liability as other income
or expense in the consolidated statements of operations.

 We
had no derivative assets or liabilities at July 31, 2025 or 2024.

 Related
Parties

 The
Company follows subtopic ASC 850-10 for the identification of related parties and disclosure of related party transactions. Pursuant
to Section 850-10-20, the related parties include: (a) affiliates of the Company ("Affiliate" means, with respect to any
specified person, any other person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is
under common control with such person, as such terms are used in and construed under Rule 405 under the Securities Act); (b) entities
for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value
Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; (c) trusts for the benefit
of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; (d) principal owners
of the Company; (e) management of the Company; (f) other parties with which the Company may deal if one party controls or can significantly
influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from
fully pursuing its own separate interests; and (g) other parties that can significantly influence the management or operating policies
of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other
to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

Liabilities

 The
Company receives payments from customers based upon contractual billing schedules. Contract liabilities include payments received in
advance of performance under the contract. Contract assets include amounts related to the Company's contractual right to consideration
for completed performance obligations not yet invoiced. Our contract assets and liabilities are reported on an individual contract basis
at the end of each reporting period. Contract liabilities are classified as current or noncurrent based on the timing of when we expect
to recognize revenue. The Company expects to recognize all outstanding contract liabilities over the next 12 months. The Company has
recorded $ 3,146 and $ 0 as of July 31, 2025, and July 31, 2024, respectively in accrued expenses related to contract liabilities.

Combination

 The
Company may execute more than one contract or agreement with a single customer. The Company evaluates whether the agreements were negotiated
as a package with a single objective, whether the amount of consideration to be paid in one agreement depends on the price and/or performance
of another agreement, or whether the goods or services promised in the agreements represent a single performance obligation. The conclusions
reached can impact the allocation of the transaction price to each performance obligation and the timing of revenue recognition related
to those arrangements. The Company applied the revenue model to a portfolio of contracts with similar characteristics where we expected
that the financial statements would not differ materially from applying it to the individual contracts within that portfolio.

 F- 10

 Revenue
Recognition

 The
Company's revenue recognition policy is to recognize revenue in accordance with ASC 606, " Revenue from Contracts with
Customers. " The Company follows the five-step model provided by ASC Topic 606 in order to recognize revenue in the following
manner: 1) Identify the contract; 2) Identify the performance obligations of the contract; 3) Determine the transaction price of the
contract; 4) Allocate the transaction price to the performance obligations; and 5) Recognize revenue. An entity recognizes revenue for
the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to
be entitled in exchange for those goods or services.

 Often
contracts contain more than one performance obligation. Performance obligations are the unit of accounting for revenue recognition and
generally represent the distinct goods or services that are promised to the customer. Revenue is recognized net of any taxes collected
and subsequently remitted to governmental authorities. If we determine that we have not satisfied a performance obligation, we defer
recognition of the revenue until the performance obligation is satisfied. The agreements are generally non-cancellable or contain significant
penalties for early cancellation, although customers typically have the right to terminate their contracts for cause if we fail to perform
material obligations. However, if non-standard acceptance periods, non-standard performance criteria, or cancellation or right of refund
terms are required, revenue is recognized upon the satisfaction of such criteria.

 Advertising
and Marketing

 Advertising
and marketing costs are expensed as incurred in accordance with ASC 720-35, " Advertising Costs." We incurred advertising
and marketing costs of $ 244,313 and $ 9,919 for the years ended July 31, 2025 and 2024, respectively, which are included in selling, general
and administrative expenses on the consolidated financial statements.

 Stock-Based

 The
Company accounts for stock-based compensation in accordance with ASC Topic 718, " Compensation – Stock Compensation"
 ("ASC 718") which establishes financial accounting and reporting standards for stock-based employee compensation. It
defines a fair value-based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation
cost for stock option plans, if any, in accordance with ASC 718.

payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of stock-based payment awards issued
to non-employees for services rendered have been recorded at the fair value of the stock-based payment, which is the more readily determinable
value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If
an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the
termination of service. Stock-based compensation expense is included in cost of goods sold or selling, general and administrative expenses,
depending on the nature of the services provided, in the consolidated statements of operations. Stock-based payments issued to placement
agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid-in capital.

 The
Company recognizes all forms of stock-based payments, including stock option grants, warrants and restricted stock grants, at their
fair value on the grant date, which are based on the estimated number of awards that are expected to vest. See Note 9 -
Stock-Based Compensation.

 Income
Taxes

 We
use the asset and liability method of accounting for income taxes in accordance with Topic 740, "Income Taxes". Under
this method, income tax expense is recognized for the amount of: (1) taxes payable or refundable for the current year and (2) deferred
tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements
or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years
in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a
change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance
is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is
more likely than not some portion or all of the deferred tax assets will not be realized.

 F- 11

 ASC
Topic 740-10-30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and
prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. ASC Topic 740-10-40 provides guidance on de-recognition, classification, interest and
penalties, accounting in interim periods, disclosure, and transition. We have no material uncertain tax positions for any of the reporting
periods presented.

 Net
Loss Per Common Share

 We
determine basic loss per share and diluted loss per share in accordance with the provisions of ASC 260, " Earnings Per Share."
Basic loss per share excludes dilution and is computed by dividing earnings available to common stockholders by the weighted average
number of common shares outstanding for the period. The calculation of diluted income loss per share is similar to that of basic earnings
per share, except the denominator is increased, if the earnings are positive, to include the number of additional common shares that
would have been outstanding if all potentially dilutive common shares had been exercised.

 Recent
Accounting Pronouncements

 In
November 2024, the FASB issued ASU 2024 - 03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation
Disclosures (Subtopic 220 - 40): Disaggregation of Income Statement Expenses, which improves financial reporting by requiring
public entities to disclose additional information about specific expense categories in the notes of the financial statements at interim
and annual reporting period. ASU 2024 - 03 is effective for all public entities for annual reporting periods beginning after
 December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating
the effect of adopting this ASU.

 In December, 2023, the FASB issued ASU No. 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures"
which requires two primary enhancements of 1) disaggregated information on a reporting entity's effective tax rate reconciliation,
and 2) information on income taxes paid. For public business entities, the new requirements will be effective for annual periods beginning
after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early
adoption is permitted. The Company is currently assessing the pronouncement and its impact on its income tax disclosures and related cash
flow disclosures, but it does not impact the Company's results of operations, or financial condition.

 NOTE
2 - INTANGIBLES

 Intangibles
consisted of the following at July 31, 2025 and 2024:

 SCHEDULE OF INTANGIBLES, NET

 As
 of July 31, 2025

 Accumulated

 Reserve for

 Cost

 Net

 Software

 $
 627,440

 $
 ( 627,440
)

 $
 -

 $
 -

 Intangible assets in-process

 252,595

 -

 -

 252,595

 Patents

 55,137

 ( 8,438
)

 ( 8,825
)

 37,874

 Website

 8,785

 ( 8,785
)

 -

 -

 Total intangibles

 $
 943,957

 $
 ( 644,663
)

 $
 ( 8,825
)

 $
 290,469

 As
 of July 31, 2024

 Accumulated

 Reserve for

 Cost

 Net

 Software

 $
 627,440

 $
 ( 209,147
)

 $
 -

 $
 418,293

 Patents

 165,411

 ( 19,112
)

 ( 57,849
)

 88,450

 Website

 8,785

 ( 8,785
)

 -

 -

 Total intangibles

 $
 801,636

 $
 ( 237,044
)

 $
 ( 57,849
)

 $
 506,743

 F- 12

 During
the years ended July 31, 2025 and 2024, the Company reassessed the existence of impairment indicators on its internally developed definite-lived
intangible assets. The Company determined that indicators of impairment existed and, as a result, a quantitative impairment analysis
was required. Management elected to abandon certain patent applications during the year. In addition, Management analyzed certain patents
that were in an office action status at year end for feasibility and probability of the success of continuing the office action process.
Based on the patent abandonments and the results of the analysis, Management concluded that the carrying amount of the patents exceeding
their fair value, which resulted in an impairment charge of $ 140,770 being recognized for the year ended July 31, 2024. The impairment
charge of $ 140,770 includes $ 82,921 for the abandonment of certain patent applications, and $ 57,849 for the establishment of an impairment
reserve against our remaining patent applications that are currently in process. For the year ended July 31, 2025, Management concluded
that the carrying amount of the patents exceeding their fair value, which resulted in an impairment charge of $ 46,225 being recognized.

expense for the years ended July 31, 2025 and 2024 was $ 421,955 and $ 221,919, respectively.

 Intangibles
are amortized over their estimated useful lives of 2
to 20
years. As of July 31, 2025, the weighted average remaining useful life of intangibles assets in-service being amortized was
approximately six ( 6)
years. We expect the remaining aggregate amortization expense for each of the five succeeding fiscal years to be as
follows:

 SCHEDULE OF INTANGIBLE ASSETS, FUTURE AMORTIZATION EXPENSE

 2026

 $
 1,378

 2027

 1,378

 2028

 1,378

 2029

 1,378

 2030

 1,378

 Thereafter

 30,984

 Total expected amortization
 expense

 $
 37,874

 NOTE
3 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 Accounts
payable and accrued expenses consisted of the following at July 31, 2025 and 2024:

 SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 July

 July

 Accounts payable

 $
 94,893

 $
 51,151

 Accrued expenses

 220,814

 55,800

 Accrued interest expense

 -

 75,833

 Total accounts payable
 and accrued expenses

 $
 315,707

 $
 182,784

 NOTE
4 - ACCOUNTS PAYABLE AND ACCRUED EXPENSES, RELATED PARTY

 Accounts
payable and accrued expenses, related party consisted of the following at July 31, 2025 and 2024:

 SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES RELATED PARTY

 July

 July

 Accounts payable, related party

 $
 2,339

 $
 30,925

 Accrued expenses, related
 party

 5,492

 156,969

 Total accounts payable
 and accrued expenses, related party

 $
 7,831

 $
 187,894

 NOTE
5 - PAYROLL RELATED LIABILITIES

 Payroll
related liabilities consisted of the following at July 31, 2025 and 2024:

 SCHEDULE OF PAYROLL RELATED LIABILITIES

 July

 July

 Accrued officers' payroll

 $
 25,836

 $
 -

 Payroll taxes payable

 16,637

 16,637

 Total payroll related
 liabilities

 $
 42,473

 $
 16,637

 F- 13

 NOTE
6 - NOTE PAYABLE, RELATED PARTY

 On
June 12, 2023, we issued a Promissory Note to Platinum Equity Advisors, LLC, a related party (the "Platinum Note 1"), in
the principal amount of $ 372,069. The Platinum Note was unsecured and beared interest at 10 % per annum. The principal amount of the note
plus accrued interest of $ 18,604 was due in a single lump sum payment on December 12, 2023. We incurred no issuance cost on the transaction
and the proceeds were used to retire debt.

 On
December 12, 2023, we issued a new promissory note to Platinum Equity Advisors, LLC in the principal amount of $ 390,673 (the "Platinum
Note 2") as full payment of the Platinum Note 1 principal and accrued interest due on such date. The Platinum Note 2 was unsecured
and beared interest at 10 % per annum. The principal amount of the note plus accrued interest of $ 19,534 was due in a single lump sum
payment on June 12, 2024. We incurred no issuance cost on the transaction.

 On
June 12, 2024, we issued a Promissory Note to Platinum Equity Advisors, LLC, a related party (the "Platinum Note 3"), in
the principal amount of $ 410,207. The Platinum Note 3 was unsecured and beared interest at 10 % per annum. The principal amount of the
note plus accrued interest of $ 20,510 was due in a single lump sum payment on December 12, 2024. We incurred no issuance cost on the
transaction.

 On
December 31, 2024, we issued a new promissory note to Platinum Equity Advisors, LLC in the principal amount of $ 373,957 (the "Platinum
Note 4") as full payment of the Platinum Note 3 principal and accrued interest due. The Platinum Note 4 is unsecured and bears
interest at 10 % per annum. The principal amount of the note plus accrued interest of $ 37,396 is due in a single lump sum payment on December
31, 2025. We incurred $ 55,945 of issuance cost on the transaction.

 Platinum
Equity Advisors, LLC is a related party and is our largest shareholder and is owned 100 % by the spouse of our CEO and Charman of our Board
of Directors.

 At
July 31, 2025, all amounts owed under Platinum Note 4 were repaid. The Company recognized a loss of $ 51,283 for the unamortized issuance
costs in extinguishment of debt on the consolidated financial statements.

 NOTE
7 – NOTES PAYABLE

 We
had the following debt obligations reflected at their respective carrying values on our consolidated balance sheets as of July 31, 2025
and 2024:

 SCHEDULE OF DEBT OBLIGATIONS

 July

 July

 5% Convertible promissory notes

 $
 -

 $
 175,000

 5 % Convertible promissory notes

 $
 -

 $
 175,000

 Note payable to Acorn
 Management Partners, LLC

 -

 50,000

 Notes payable

 $
 -

 $
 225,000

 5%
Convertible Promissory Notes

 On
various dates during the month of March 2018, we issued a series of 5 % Convertible Promissory Notes (collectively, the " 5 % Notes")
totaling $ 750,000 in net proceeds. We incurred no costs related to the issuance of the 5 % Notes. The 5 % Notes bear interest at the rate
of five percent ( 5 %) per annum, compounded annually and matured one-year from the date of issuance. At July 31, 2025, and July 31, 2024,
accrued but unpaid interest on the 5 % Notes was $ 0 and $ 63,914, respectively, which is included in "Accounts payable and accrued
expenses" on our interim consolidated balance sheets.

 The
5% Notes are convertible into common shares of the Company at a fixed ratio of two shares of common stock per dollar amount of the face
value of the note. The principal terms under which the 5 % Notes may be converted into common stock of the Company are as follows:

 At
 the option of the holder, the outstanding principal amount of the note, and any accrued but unpaid interest due, may be converted
 into the Company's common stock at any time prior to the maturity date of the note.

 F- 14

 The
 outstanding principal amount of the note, and any accrued but unpaid interest due, will automatically be converted into the Company's
 common stock if at any time prior to the maturity date of the note, the Company concludes a sale of equity securities in a private
 offering resulting in gross proceeds to the Company of at least $1,000,000.

 At
July 31, 2025, all outstanding 5 % Notes were settled for common stock. Management negotiated an amendment with all remaining noteholders
extending the maturity date and subsequently converted all outstanding 5 % Notes resulting in a gain of $ 151,508 that was recognized in
extinguishment of debt on the interim consolidated financial statements.

 Note
Payable to Acorn Management Partners, LLC

 On
August 11, 2020, we agreed to repurchase 1,000,000 shares of our common stock from Acorn Management Partners, LLC ("AMP").
As consideration for the share repurchase, we issued a $ 50,000 promissory note bearing interest a 6.0 % per annum and due 1 one-year from
the date of issuance (the "Acorn Note"). In the event we default under the terms of the Acorn Note, we were required to deliver
 1,000,000 shares of our common stock back to AMP in full satisfaction of the obligation. The purchased shares were delivered by AMP directly
to the transfer agent on September 8, 2020, and immediately cancelled. At July 31, 2025, and July 31, 2024, accrued but unpaid interest
on the Acorn Note was $ 0 and $ 11,919, respectively, which is included in "Accounts payable and accrued expenses" on our consolidated balance sheets. At July 31, 2025, the note was repaid, and the related accrued interest was extinguished. Management negotiated
a settlement of the entire outstanding principal balance and accrued interest resulting in a gain of $ 13,419 that was recorded in extinguishment of debt on the interim consolidated financial statements.

 NOTE
8 - INCOME TAXES

 A
reconciliation of the provision for income taxes as reported, and the amount computed by multiplying net loss by the federal statutory
rate of 21 % as of July 31, 2025 and 2024 are as follows:

 SCHEDULE OF RECONCILIATION OF PROVISION FOR INCOME TAXES

 July

 July

 Federal income tax benefit computed
 at the statutory rate

 $
 ( 974,100
)

 $
 ( 147,522
)

 Increase (decrease) resulting from:

 Stock-based compensation

 192,908

 39,195

 Derivatives

 -

 -

 Valuation allowance

 760,445

 107,283

 Other

 20,747

 1,044

 Income tax benefit,
 as reported

 $
 -

 $
 -

 The
components of the net deferred tax asset as of July 31, 2025 and 2024 are as follows:

 SCHEDULE OF COMPONENTS OF NET DEFERRED TAX ASSET

 July

 July

 Deferred tax assets:

 Net operating
 loss carryovers

 $
 1,817,718

 $
 1,057,273

 Valuation
 allowance

 ( 1,817,718
)

 ( 1,057,273
)

 Net deferred tax asset,
 as reported

 $
 -

 $
 -

 In
assessing the realizable value of deferred tax assets, management considers whether it is more likely than not that some portion or all
the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon generation of future
taxable income during the periods in which these temporary differences become tax deductible. Based on management's assessment
of objective and subjective evidence, we have concluded at this time it is more likely than not that all of our deferred tax asset will
not be realized and we have provided a valuation allowance for the entire amount of the deferred tax asset. At July 31, 2025, we have
approximately $ 8.6 million in federal and state net operating loss carryovers that begin expiring in fiscal 2037.

 F- 15

 The
Company evaluated the provisions of ASC 740 related to the accounting for uncertainty in income taxes recognized in an enterprise's
financial statements. ASC 740 prescribes a comprehensive model for how a company should recognize, present, and disclose uncertain positions
that the Company has taken or expects to take in its tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the net benefit recognized and measured pursuant to the interpretation are referred to as "unrecognized benefits." A
liability is recognized (or amount of net operating loss carry forward or amount of tax refundable is reduced) for unrecognized tax benefit
because it represents an enterprise's potential future obligation to the taxing authority for a tax position that was not recognized
as a result of applying the provisions of ASC 740.

 If
applicable, interest costs related to the unrecognized tax benefits are required to be calculated and would be classified as Other expenses
– Interest expense in the consolidated statements of operations. Penalties would be recognized as a component of "General
and administrative."

 No
interest or penalties on unpaid tax were recorded during the years ended July 31, 2025 and 2024. As of July 31, 2025 and 2024, no liability
for unrecognized tax benefits was required to be reported. The Company does not expect any significant changes in its unrecognized tax
benefits in the next year.

 NOTE
9 - STOCK-BASED COMPENSATION

 Our
stock-based compensation programs are long-term retention awards that are intended to attract, retain, and provide incentives for employees,
officers and directors, and to align stockholder and employee interest. We utilize grants of both stock options and warrants and restricted
stock to achieve those goals.

 Summary
of Stock Options and Warrants

 During
the year ended July 31, 2025, we recorded no compensation expense related to stock options and warrants. During the year ended July 31,
2024, we recorded $ 76,482 of compensation expense related to stock options and warrants. The Company granted no stock options or warrants
during the year ended July 31, 2025. The grant date fair value of stock options and warrants during the year ended July 31, 2024 was
$ 69,776.

 The
following table summarizes our options and warrant activity for the years ended July 31, 2025 and 2024:

 SCHEDULE OF OPTIONS AND WARRANTS ACTIVITY

 July

 July

 Number of

 Weighted

 Number of

 Weighted

 Options and

 Average

 Options and

 Average

 Warrants

 Exercise
 Price

 Warrants

 Exercise
 Price

 Balance at beginning of year

 6,350,000

 $
 0.21

 6,350,000

 $
 0.24

 Granted

 -

 -

 1,250,000

 0.07

 Canceled

 ( 1,500,000
)

 0.10

 ( 1,250,000
)

 0.23

 Expired

 ( 2,600,000
)

 0.20

 -

 -

 Balance at end of period

 2,250,000

 $
 0.22

 6,350,000

 $
 0.21

 Options and warrants
 exercisable

 2,250,000

 $
 0.22

 6,350,000

 $
 0.21

 F- 16

 Summary
of Restricted Stock Grants

 During
the years ended July 31, 2025 and 2024, we recorded compensation expense related to restricted stock grants of $ 1,575,211 and $ 55,661,
respectively.

 The
following table summarizes our restricted stock activity for the years ended July 31, 2025 and 2024:

 SCHEDULE OF RESTRICTED STOCK ACTIVITY

 July

 July

 Balance at beginning of period

 4,000,000

 2,282,031

 Granted

 13,280,000

 3,100,000

 Cancelled

 ( 2,650,000
)

 Released

 ( 3,000,000
)

 ( 1,382,031
)

 Balance at end of period

 11,630,000

 4,000,000

 The
grant date fair value of restricted stock awards during the years ended July 31, 2025 and 2024 was $ 1,834,444 and $ 172,518, respectively.

 NOTE
10 - COMMON STOCK

 On
July 31, 2025 and July 31, 2024, we had 185,497,862 and 79,853,696 shares of common stock outstanding, respectively. We issued 105,644,166
unregistered shares of our common stock, of which 92,626,548 shares were issued for cash, 2,034,155 shares for a loan modification fee,
 493,463 were issued for conversion of debt and related accrued interest,
 1,160,000 shares were issued for services and 9,330,000 were issued for compensation during the twleve months ended July 31, 2025. During
the fiscal year ended July 31, 2024, we issued 11,837,529 unregistered shares of our common stock, of which 5,500,000 shares were issued
for cash, 3,385,154 shares were issued for the payment of accrued expenses, 1,282,031 were issued for compensation, 1,100,000 shares
were issued for services, and 570,344 shares were issued for a loan modification fee.

 On
August 25, 2024, we issued 1,000,000 unregistered shares of our common stock to a member of our Board of Directors as compensation for
serving on the Board and for providing certain other business advisory services. The shares were issued upon the vesting of shares from
a restricted stock award dated August 25, 2024 at an estimated grant date fair value of $ 0.0675 per share on such date.

 On
September 1, 2024, we issued 250,000 unregistered shares of our common stock to a consultant pursuant to the terms of a consulting agreement.
The shares were issued upon the vesting of shares from a restricted stock award dated September 1, 2024, at an estimated grant date fair
value of $ 0.035 per share on such date.

 On
September 20, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
September 26, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
October 8, 2024, we completed multiple private placements of 2,000,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 200,000. We incurred no cost related to the private placements.

 On
October 10, 2024, we completed multiple private placements of 3,500,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 350,000. We incurred no cost related to the private placements.

 F- 17

 On
October 18, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
October 19, 2024, we issued 500,000 shares of common stock to consultants pursuant to the terms of their consulting agreements entered
on October 19, 2022. These shares were issued to the consultants at an estimated value of $ 0.033 per share.

 On
October 21, 2024, we completed multiple private placements of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placements.

 On
October 22, 2024, we completed multiple private placements of 2,000,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 200,000. We incurred no cost related to the private placements.

 On
October 24, 2024, we completed multiple private placements of 2,300,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 230,000. We incurred no cost related to the private placements.

 On
October 25, 2024, we completed multiple private placements of 6,520,000 unregistered shares of our common stock at a price of $ 0.10 per
share resulting in net proceeds to the Company of $ 652,000. We incurred no cost related to the private placements.

 On
October 25, 2024, we issued 281,240 unregistered shares of our common stock for settlement of accounts payables. The shares were issued
at an agreed upon value of $ 0.10 per share.

 On
October 29, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
October 29, 2024, we issued 1,000,000 unregistered shares of our common stock to the Chief Strategy Officer. The shares were issued to
the officer at an estimated grant date fair value of $ 0.10 per share.

 On
October 31, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
November 1, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
November 5, 2024, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
November 6, 2024, we completed a private placement of 200,000 unregistered shares of our common stock at a price of $ 0.10 per share resulting
in net proceeds to the Company of $ 20,000. We incurred no cost related to the private placement.

 F- 18

 On
November 11, 2024, we completed a private placement of 2,000,000 unregistered shares of our common stock at a price of $ 0.10 per share
resulting in net proceeds to the Company of $ 200,000. We incurred no cost related to the private placement.

 On
November 13, 2024, we issued 500,000 shares of common stock to a previous lender pursuant to a make-whole provision included as part
of a loan modification fee. The shares were issued at an estimated value of $ 0.0665 per share.

 On
November 19, 2024, we issued 60,000 unregistered shares of our common stock for settlement of accounts payables. The shares were issued
at an agreed upon value of $ 0.14 per share.

 On
December 1, 2024, we issued 250,000 shares of common stock to a consultant pursuant to the terms of their consulting agreement. The shares
were issued to the consultants at an estimated value of $ 0.09 per share.

 On
December 1, 2024, we issued 2,000,000 unregistered shares of our common stock to the Chief Financial Officer. The shares were issued
to the officer at an estimated grant date fair value of $ 0.09 per share.

 On
December 5, 2024, we issued 2,000,000 shares of common stock to a consultant pursuant to the terms of their consulting agreement. The
shares were issued to the consultants at an estimated value of $ 0.119 per share.

 On
December 20, 2024, we issued 500,000 unregistered shares of our common stock to a member of our Board of Directors as compensation for
serving on the Board at their resignation. The shares were issued as part of a settlement agreement at an estimated grant date at a fair
value of $ 0.077 per share.

 On
January 1, 2025, we issued 250,000 shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares
were issued to the consultants at an estimated value of $ 0.105 per share.

 On
January 2, 2025, we issued 100,000 shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares
were issued to the consultants at an estimated value of $ 0.107 per share.

 On
January 6, 2025, we completed a private placement of 909,091 unregistered shares of our common stock at a price of $ 0.11 per share resulting
in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
January 15, 2025, we completed a private placement of 793,650 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
January 20, 2025, we issued 150,000 shares of common stock to consultants pursuant to the terms of their consulting agreement. The shares
were issued to the consultants at an estimated value of $ 0.135 per share.

 On
January 24, 2025, we completed a private placement of 793,650 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private placement.

 On
January 26, 2025, we completed multiple private placements of 4,799,566 unregistered shares of our common stock at a price of $ 0.123
per share resulting in net proceeds to the Company of $ 590,200. We incurred no cost related to the private placements.

 On
January 27, 2025, we completed multiple private placements of 2,587,300 unregistered shares of our common stock at a price of $ 0.126
per share resulting in net proceeds to the Company of $ 326,000. We incurred no cost related to the private placements.

 On
January 28, 2025, we completed multiple private placements of 6,793,650 unregistered shares of our common stock at a price of $ 0.126
per share resulting in net proceeds to the Company of $ 856,000. We incurred no cost related to the private placements.

 F- 19

 On
January 29, 2025, we completed multiple private placements of 9,813,056 unregistered shares of our common stock at a price of $ 0.125
per share resulting in net proceeds to the Company of $ 1,221,900. We incurred no cost related to the private placements.

 On
January 30, 2025, we completed multiple private placements of 4,380,951 unregistered shares of our common stock at a price of $ 0.126
per share resulting in net proceeds to the Company of $ 552,000. We incurred no cost related to the private placements.

 On
January 31, 2025, we completed multiple private placements of 3,974,600 unregistered shares of our common stock at a price of $ 0.126
per share resulting in net proceeds to the Company of $ 500,800. We incurred no cost related to the private placements.

 On
February 3, 2025, we completed multiple private placements of 4,702,741 unregistered shares of our common stock at a price of $ 0.120
per share resulting in net proceeds to the Company of $ 562,000. We incurred no cost related to the private transaction.

 On
February 4, 2025, we completed a private placement of 793,650 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private transaction.

 On
February 5, 2025, we completed a private placement of 3,000,000 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 378,000. We incurred no cost related to the private transaction.

 On
February 6, 2025, we completed multiple private placements of 3,502,740 unregistered shares of our common stock at a price of $ 0.122
per share resulting in net proceeds to the Company of $ 426,800. We incurred no cost related to the private transaction.

 On
February 7, 2025, we completed multiple private placements of 3,405,483 unregistered shares of our common stock at a price of $ 0.117
per share resulting in net proceeds to the Company of $ 400,000. We incurred no cost related to the private transaction.

 On
February 10, 2025, we completed multiple private placements of 1,793,651 unregistered shares of our common stock at a price of $ 0.126
per share resulting in net proceeds to the Company of $ 226,000. We incurred no cost related to the private transaction.

 On
February 11, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.11 per share
resulting in net proceeds to the Company of $ 110,000. We incurred no cost related to the private transaction.

 On
February 12, 2025, we completed a private placement of 454,545 unregistered shares of our common stock at a price of $ 0.11 per share
resulting in net proceeds to the Company of $ 50,000. We incurred no cost related to the private transaction.

 On
February 14, 2025, we issued 750,000 shares of common stock to multiple consultants pursuant to the terms of their consulting agreements.
These shares were issued to the consultants at an estimated value of $ 0.051 per share.

 On
February 18, 2025, we completed multiple private placements of 2,500,000 unregistered shares of our common stock at a price of $ 0.113
per share resulting in net proceeds to the Company of $ 283,000. We incurred no cost related to the private transaction.

 On
February 20, 2025, we completed a private placement of 793,651 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private transaction.

 F- 20

 On
February 21, 2025, we completed a private placement of 793,650 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 100,000. We incurred no cost related to the private transaction.

 On
February 26, 2025, we completed a private placement of 1,590,909 unregistered shares of our common stock at a price of $ 0.11 per share
resulting in net proceeds to the Company of $ 175,000. We incurred no cost related to the private transaction.

 On
February 26, 2025, we issued 790,794 shares of common stock to a previous lender pursuant to a make-whole provision included as part
of a loan modification fee. The shares were issued at an estimated value of $ 0.0665 per share.

 On
February 27, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.126 per share
resulting in net proceeds to the Company of $ 126,000. We incurred no cost related to the private transaction.

 On
March 1, 2025, we issued 250,000 shares of common stock to a consultant pursuant to the terms of their consulting agreements. These shares
were issued to the consultants at an estimated value of $ 0.232 per share.

 On
March 21, 2025, we completed a private placement of 1,136,364 unregistered shares of our common stock at a price of $ 0.11 per share resulting
in net proceeds to the Company of $ 125,000. We incurred no cost related to the private transaction.

 On
March 21, 2025, we issued 211,214 shares of common stock to multiple holders of our 5 % Convertible Promissory Notes in exchange for the
Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of
$ 0.50 per share.

 On
March 25, 2025, we issued 70,523 shares of common stock to multiple holders of our 5 % Convertible Promissory Notes in exchange for the
Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of
$ 0.50 per share.

 On
March 26, 2025, we issued 70,513 shares of common stock to multiple holders of our 5 % Convertible Promissory Notes in exchange for the
Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of
$ 0.50 per share.

 On
April 1, 2025, we issued 150,000 unregistered shares of our common stock to a consultant pursuant to the terms of a consulting agreement
at an estimated grant date fair value of $ 0.234 per share on such date.

 On
April 5, 2025, we issued 141,213 shares of common stock to multiple holders of our 5 % Convertible Promissory Notes in exchange for the
Note plus accrued interest through the conversion date. Under the terms of the Note, the shares were issued at a conversion price of
$ 0.50 per share.

 On
April 14, 2025, we completed a private placement of 793,650 unregistered shares of our common stock at a price of $ 0.126 per share resulting
in net proceeds to the Company of $ 100,000. We incurred no cost related to the private transaction.

 On
April 17, 2025, we issued 500,000 unregistered shares of our common stock to the Chief Revenue Officer. The shares were issued to the
officer at an estimated grant date fair value of $ 0.229 per share.

 On
April 24, 2025, we issued 80,000 unregistered shares of our common stock to a member of our Board of Directors as compensation for serving
on the Board and for providing certain other business advisory services at an estimated grant date fair value of $ 0.223 per share.

 On
May 13, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.126 per share resulting
in net proceeds to the Company of $ 126,000. We incurred no cost related to the private transaction.

 F- 21

 On
May 27, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.126 per share resulting
in net proceeds to the Company of $ 126,000. We incurred no cost related to the private transaction.

 On
May 28, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.126 per share resulting
in net proceeds to the Company of $ 126,000. We incurred no cost related to the private transaction.

 On
June 4, 2025, we completed a private placement of 1,000,000 unregistered shares of our common stock at a price of $ 0.126 per share resulting
in net proceeds to the Company of $ 126,000. We incurred no cost related to the private transaction.

 On
June 25, 2025, we issued 462,121 shares of common stock to a previous lender pursuant to a make-whole provision included as part of a
loan modification fee. The shares were issued at an estimated value of $ 0.0665 per share.

 NOTE
11 - RELATED PARTY TRANSACTIONS

 The
Company has periodically obtained loans from related parties, primarily shareholders for which there are no formal written
commitment for continued support by shareholders or others. Amounts loaned primarily relate to amounts paid to vendors. The loans
are considered temporary in nature and have not been formalized by any written agreement. As of July 31, 2025 and 2024, related
parties were owed $ 2,339
and $ 30,925,
respectively, which are included in Accounts payable and accrued expenses, related party on the consolidated balance sheets (See Note
4 - Accounts Payable and Accrued Expenses, Related Party). The amounts owed are payable on demand and carry no interest.
The amounts and terms of the related party loans may not necessarily be indicative of the amounts and terms that would have been
incurred had comparable transactions been entered into with independent third parties.

 For
compensation after August 1, 2023, we entered into a Non-Employee Chief Executive Officer Engagement Agreement (the "Contract
CEO Agreement") with Platinum Equity Advisors, LLC ("Platinum Equity"), a related party, to provide the services
of our CEO and Chairman of the Board of Directors. Platinum Equity Advisors, LLC is a related party, is our largest shareholder, and
is owned 100 %
by the spouse of our CEO and Charman of our Board of Directors. At July 31, 2025 and 2024, we owed Platinum Equity $ 5,492
and $ 151,386,
respectively, for amounts related to the Contract CEO Agreement. The amount owed is included in Accounts payable and accrued
expenses, related party on the interim consolidated balance sheets (See Note 4 - Accounts Payable and Accrued Expenses, Related
Party).

 On
December 31, 2024, we issued a Promissory Note to Platinum Equity Advisors, LLC in the principal amount of $ 373,957 which included $ 51,283
of unamortized deferred financing costs (See Note 6 – Notes Payable, Related Party). At July 31, 2025 all outstanding balances
were paid off. The note, plus accrued interest, is due on December 12, 2024. At July 31, 2024, accrued but unpaid interest on the note
was $ 5,583 (See Note 4 – Accounts Payable and Accrued Expenses, Related Party). The amount and terms of the related
party loan may not necessarily be indicative of the amount and terms that would have been incurred had comparable transactions been entered
into with independent third parties. On June 12, 2024, the company issued a Promissory Note to Platinum Equity Advisors, LLC in the principal
amount of $ 410,207 (See Note 6 – Notes Payable, Related Party). The note, plus accrued interest, is due on December 12, 2024. At
July 31, 2024, accrued but unpaid interest on the note was $ 5,583.

 For
the fiscal year ending July 31, 2025, the Company recognized $ 57,006 in office rent expense included in "Selling, general and administrative"
on our consolidated statements of operations related to a month-to-month sublease agreement with Blue Earth Resources, Inc. ("BERI"),
an entity related to the Company through common management control for use of certain office space.

 F- 22

 NOTE
12 - COMMITMENTS AND CONTINGENCIES

 Litigation

 As
previously reported, on September 18, 2023, Apex Funding Source, LLC ("Apex") filed a lawsuit in the Supreme Court of
the State of New York, County of New York, alleging breach by Blue Earth Resources, Inc. ("BERI") of a loan agreement
and alleged failure to pay $ 4,705,900
in principal and interest to Apex when due. The suit names Scott M. Boruff, our CEO and Chairman of the Company's Board of
Directors, "Grasshopper Staffing, Inc.," and "Indeliving Holdings, Inc.," as defendants in the suit. Apex
alleges that Grasshopper Staffing, Inc. and IndeLiving Holdings, Inc. are each guarantors of the loan to BERI, which is an entity
that has common management personnel with our Company. Our Company ceased using the Grasshopper Staffing, Inc. name years before the
facts underlying the dispute arose, and IndeLiving Holdings, Inc. was a wholly-owned subsidiary of our Company that has been
administratively dissolved.

 On
April 18, 2024, Apex filed a motion seeking partial summary judgment against BERI and Mr. Boruff in the amount of $ 4,705,900,
plus their actual and reasonable attorneys' fees. Neither
Grasshopper Staffing, Inc. nor IndeLiving Holdings, Inc. was included in the order granting partial summary judgment.

 In
the event Apex attempts to enforce the alleged guarantees against our Company, which is not itself a named party to the proceedings,
we believe we have valid defenses. In the judgment of the Company's management, even if the remaining actions were adversely
determined, they would not be reasonably likely to have a direct or indirect material adverse effect on the Company because no remaining subsidiaries exist. Based on the disposition of the claims against BERI and Mr. Boruff summarized above, we do not
expect to provide any further updates on this matter.

 Other than the foregoing, there are no material pending
legal proceedings, other than ordinary routine litigation incidental to our business, to which we or any of our subsidiaries are a part
or of which any of our property is the subject.

 Operating
Leases

 The
Company has lease agreements for certain personal and real property with initial lease terms of 12 months or less that are not recorded
on the balance sheet. Our lease agreements do not include any significant renewal options. Our lease agreements do not contain any material
residual value guarantees or material restrictive covenants.

 Employment
and Consulting Agreements

 On
January 31, 2024, we entered into a Non-Employee Chief Executive Officer Engagement Agreement (the "Contract CEO Agreement")
with Platinum Equity Advisors, LLC ("Platinum") to provide the services of Scott M. Boruff as Chief Executive Officer and
Chairman of the Board of Directors of the Company for a term of three (3) years. Effective as of August 1, 2023, the Company shall pay
Platinum an annual base fee of $ 102,000. The initial base fee is intended to compensate Platinum for a time commitment of up to 1/3 of
the CEO's time, attention, skill and best efforts to the Company. At the discretion of the Board of Directors, the base fee may
be increased to a maximum annual amount of $ 306,000 to better reflect the value of any future increases in the CEO's time commitment
to the Company. Effective August 1, 2024, the board set the base fee at $ 240,000 annually. If the Contract CEO Agreement is terminated
by us without cause or by Platinum for good reason, we are obligated to pay Platinum severance equal to three (3) months base fee and
any other earned but unpaid compensation. In addition, if at any time during the term of the Contract CEO Agreement Platinum is terminated
by us without cause within two years after a Change in Control of our company, or in the 90 days prior the Change in Control at the request
of the acquiror, we are obligated to pay Platinum an amount equal to 2.99 times the annual base fee. "Change in Control"
is defined in the Contract CEO Agreement to mean the acquisition by any person of beneficial ownership of our securities representing
greater than 50% of the combined voting power of our then outstanding voting securities. Platinum is eligible for equity awards and other
benefits as approved by the Board of Directors. On January 29, 2025, the agreement was updated, and the executive became entitled to
a 5% override on any and all Company sales, including initial sales and subsequent recurring sales. No overrides will be considered earned
by the Company until the amount is collected from the customer. On October 1, 2025, the annual compensation was increased to $ 315,000.

 On
January 31, 2024, in connection with the appointment of Susan A. Reyes, MD as Chief Medical Officer of the Company, the Company and Dr.
Reyes entered into an employment agreement (the "Reyes Employment Agreement") with an initial term of Three (3) years. Effective
as of August 1, 2023, the Company shall pay Dr. Reyes a base salary at the rate of $ 24,000 per annum. The initial base salary is intended
to compensate Dr. Reyes for a fractional devotion of her time, attention, skill and best efforts to the Company. At the discretion of
the Chief Executive Officer, the base salary may be increased to a maximum annual amount of $ 92,000 to better reflect the value of any
future increases in Dr. Reyes' time commitment to the Company. In the event Dr. Reyes' employment with the Company is terminated
without cause, Dr. Reyes shall be entitled to a severance payment equal to her currently in effect base salary for one (1) full year.
If Dr. Reyes is terminated without cause within two (2) years of a change in control upon request of the acquiror, Dr. Reyes shall be
entitled to a severance payment in an amount equal to 2.99 times the annualized base salary she is then earning. In addition, Dr. Reyes
is eligible for equity awards and other benefits as approved by the Board of Directors.

 F- 23

 On
January 1, 2025, we entered into a Non-Employee President & Chief Strategy Officer Engagement Agreement with All Things New Ventures,
LLC to engage Dustin M. Hillis to provide the services of President & Chief Strategy Officer to the Company for a term of Three (3)
years. The Company shall pay Mr. Hillis an annual base fee of $100,000, to be paid in equal monthly payments. In addition to the base
fee, Mr. Hillis will be paid a commission on certain new and recurring business sales. In the event Mr. Hillis' employment with
the Company is terminated without cause, Mr. Hillis shall be entitled to a severance payment equal to his currently in effect base salary
plus overrides for one (1) full year. If Mr. Hillis is terminated without cause within two (2) years of a change in control upon request
of the acquiror, Mr. Hillis shall be entitled to a severance payment in an amount equal to 2.99 times the annualized base salary plus
overrides he is then earning. In addition, Mr. Hillis is eligible for equity awards and other benefits as approved by the Board of Directors.
Mr. Hillis became entitled to a 5% override on any and all Company sales, including initial sales and subsequent recurring sales. No
overrides will be considered earned by the Company until the amount is collected from the customer. A First Amendment was signed effective
April 1, 2025, and the annual base fee was increased to $ 150,000 paid in equal monthly payments. On October 1, 2025, the annual compensation
was increased to $ 225,000.

 Effective
as of October 1, 2024, Timothy R. Brady was appointed by the Board of Directors (the "Board") of SafeSpace Global Corporation to the position of Chief Financial Officer. Mr. Brady initially served as our Chief Financial Officer
on a fractional basis and commenced service as Chief Financial Officer on a full-time basis as of December 1, 2024. In connection with
the commencement of his full-time service to the Company in December, the Company entered into a Non-Employee Chief Financial Officer
Engagement Agreement dated December 1, 2024. Pursuant to the agreement, Mr. Brady is entitled to an initial monthly base salary of $ 10,000
and received 2,000,000 shares of the Company's common stock. The Board or its compensation committee may grant Mr. Brady other
long-term incentive awards in the form of equity awards, cash incentives or otherwise, from time to time and in the discretion of the
Board or its committee. Mr. Brady is also entitled to a 2% override on any and all Company sales, including initial sales and subsequent
recurring sales. No overrides will be considered earned by the Company until the amount is collected from the customer. The Company has
agreed to pay Mr. Brady an annual bonus subject to achievement by the Company of Board-established corporate goals and to recognized
other achievements by the Company or Mr. Brady during the year. Mr. Brady is entitled to participate in any employee benefit plans, programs
and arrangements of the Company in effect during the engagement period which are generally available to other senior executives of the
Company (including, without limitation, group medical insurance plans, life insurance plans, and 401(k) plans), subject to and on a consistent
basis with the terms, conditions and overall administration of such plans, programs and arrangements. A First Amendment was signed effective
April 1, 2025, and the monthly base salary was increased to $ 12,500. At the discretion of the Board of Directors, Executive's Base
Fee may be increased. On October 1, 2025, the annual compensation was increased to $ 225,000.

 On
April 10, 2025, we appointed Mr. Anand Ijju, as our Chief Technology Officer (CTO). Mr. Ijju's employment with the Company will
begin on May 1, 2025. Mr. Ijju entered into a three-year agreement with the Company. As compensation, the Company agreed to pay Mr. Ijju
an annual salary of $ 150,000 and Mr. Ijju is entitled to discretionary bonuses as may be awarded from time to time by the Company's
Board of Directors. As additional compensation the Company granted Mr. Ijju a stock grant of 500,000 shares of the Company's common
stock. The stock grant shall be non-qualified and shall become vested annually over three years beginning on May 1, 2026. Mr. Ijju is
entitled to participate in any employee benefit plans, programs and arrangements of the Company in effect during the engagement period
which are generally available to other senior executives of the Company (including, without limitation, group medical insurance plans,
life insurance plans, and 401(k) plans), subject to and on a consistent basis with the terms, conditions and overall administration of
such plans, programs and arrangements.

 On
April 17, 2025, we appointed Mr. Theo Davies, as our Chief Revenue Officer (CRO), effective immediately. Mr. Davies was previously our
Chief Commercial Officer. As compensation, the Company agreed to pay Mr. Davies an annual salary of $ 150,000 and Mr. Davies is entitled
to discretionary bonuses as may be awarded from time to time by the Company's Board of Directors. As additional compensation the
Company granted Mr. Davies a stock grant of 500,000 shares of the Company's common stock, which vested immediately. Mr. Davies
will also receive an annual health insurance benefit allowance of $ 1,800. In addition, Mr. Davies shall be paid a 2.0% commission on
the gross amount of any and all Company domestic revenue and 5.0% commission on the gross amount of any and all Company international
revenue, the 5% commission will be reduced to 2%, when Mr. Davies finds his replacement.

 NOTE
13 - SUBSEQUENT EVENTS

 We
evaluate subsequent events and transactions that occur after the balance sheet date for the period presented and up to the issuance date
of the financial statements. Based on our review, we did not identify any subsequent events other than those listed above that would
require adjustment to or disclosure in the consolidated financial statements.

 F- 24